US6824570B2 - Composition for dyeing human keratin fibres, comprising a particular monocationic monoazo dye - Google Patents

Composition for dyeing human keratin fibres, comprising a particular monocationic monoazo dye Download PDF

Info

Publication number
US6824570B2
US6824570B2 US10/254,798 US25479802A US6824570B2 US 6824570 B2 US6824570 B2 US 6824570B2 US 25479802 A US25479802 A US 25479802A US 6824570 B2 US6824570 B2 US 6824570B2
Authority
US
United States
Prior art keywords
chosen
radicals
formula
dimethyl
phenylazo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related, expires
Application number
US10/254,798
Other versions
US20030106169A1 (en
Inventor
Laurent Vidal
Aziz Fadli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Assigned to L'OREAL S.A. reassignment L'OREAL S.A. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: FADLI, AZIZ, VIDAL, LAURENT
Publication of US20030106169A1 publication Critical patent/US20030106169A1/en
Application granted granted Critical
Publication of US6824570B2 publication Critical patent/US6824570B2/en
Adjusted expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/10Preparations for permanently dyeing the hair

Definitions

  • the present invention relates to a dye composition for dyeing human keratin fibres, such as hair, comprising at least one monocationic monoazo dye.
  • the present invention also relates to the processes for dyeing human keratin fibres, such as hair, using such a composition.
  • the present invention further relates to novel monocationic monoazo compounds.
  • oxidation bases such as ortho- or para-phenylenediamines, ortho- or para-aminophenols, and heterocyclic compounds.
  • oxidation bases are generally colourless or weakly coloured compounds that, when combined with oxidizing agents, may give rise to coloured compounds by a process of oxidative condensation.
  • couplers or colour modifiers may be chosen, for example, from aromatic meta-diamines, meta-aminophenols, meta-diphenols, and certain heterocyclic compounds such as indole compounds.
  • This oxidation dyeing process comprises applying to the keratin fibres, oxidation bases or a mixture of oxidation bases and couplers, with an oxidizing agent, for example, aqueous hydrogen peroxide; leaving the mixture to stand on the fibres; and then rinsing the fibres.
  • the colorations which result from the oxidation dyeing process can be permanent, strong, and resistant to external agents, such as light, bad weather, washing, perspiration, and rubbing.
  • the oxidation dyeing process which is generally applied at basic pH, makes it possible to obtain dyeing and simultaneously lightening of the fibre, making it possible to obtain a final coloration that is lighter than the original colour. Additionally, the lightening of the fibre can have the advantageous effect of giving rise to a uniform colour in the case of grey hair, and, in the case of naturally pigmented hair, of bringing the colour out, i.e., of making it more visible.
  • nitrobenzene, anthraquinone or nitropyridine direct dyes, azo, xanthene, acridine or azine dyes or triarylmethane dyes It is also a known practice, for example, to use nitrobenzene, anthraquinone or nitropyridine direct dyes, azo, xanthene, acridine or azine dyes or triarylmethane dyes.
  • the resulting colorations from the direct dyes can be chromatic colorations that can, however, be temporary or semi-permanent.
  • the nature of the interactions that bind the direct dyes to the keratin fibre, and their desorption from the surface and/or from the core of the fibre, can be responsible for their weak dyeing capacity, and for their poor resistance to washing or to perspiration.
  • These direct dyes can also be sensitive to light due to the poor resistance of the chromophore to photochemical attacks that lead, over time, to a dulling of the coloration of the hair. Additionally, their sensitivity to light is dependent on whether they are distributed uniformly or in aggregates in the keratin fibre.
  • direct dyes in combination with oxidizing agents.
  • the direct dyes can be sensitive to the action of oxidizing agents such as aqueous hydrogen peroxide, and reducing agents such as sodium bisulphite, which generally makes them difficult to use in lightening direct dye compositions based on aqueous hydrogen peroxide and on a basifying agent, or in oxidation dyeing compositions in combination with precursors such as oxidation bases or couplers.
  • patent application FR 2 741 798 described dye compositions containing direct dyes comprising at least one quarternized nitrogen atom of the azo or azomethine type, wherein said compositions need to be mixed extemporaneously at basic pH with an oxidizing composition.
  • These compositions make it possible to obtain colorations with homogeneous, durable, and brilliant glints. However, they may not dye keratin fibres with as much strength as oxidation dyeing compositions.
  • chromatic direct dyes which can dye human keratin fibres as strongly as oxidation dyes, and/or can be as stable as oxidation dyes when exposed to light, bad weather, washing, and perspiration. Additionally, there is a need for chromatic direct dyes that can be sufficiently stable in the presence of oxidizing and reducing agents to be able to obtain simultaneously a lightening of the fibre either by using direct lightening compositions comprising them, or by using oxidation dye compositions based on oxidation dye precursors comprising them. There is also a need for direct dyes which can dye human keratin fibres in a wide range of colours, such as chromatic colours, as well as the “fundamental” shades such as blacks and browns.
  • the present invention therefore relates to a composition for dyeing human keratin fibres, such as hair, comprising, in a cosmetically acceptable medium, at least one monocationic monoazo dye of formula (I) below:
  • W 1 is chosen from 5-, 6-, 7- and 8-membered heterocycles of formula (II) below:
  • W 2 is chosen from divalent, aromatic, and carbon-based pyridines and pyridazines of formula (III) below:
  • W 3 is chosen from cationic heteroaromatic radicals of formula (IV) below:
  • n 0, 1, 2 or 3, provided that when n is greater than or equal to 2, then the R 4 radicals may be identical or different,
  • X 1 is chosen from a nitrogen atom and CR 7 radicals
  • X 2 is chosen from a nitrogen atom and CR 8 radicals
  • Z 1 is chosen from CHR 2 radicals, oxygen and sulphur atoms, and NR 14 radicals,
  • Z 2 is chosen from oxygen and sulphur atoms, and NR 15 radicals,
  • R 0 , R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 and R 12 which may be identical or different, are each chosen from a hydrogen atom, linear and branched C 1 -C 10 hydrocarbon-based chains, possibly forming at least one carbon-based ring comprising from 3 to 6 members, and being saturated or unsaturated, wherein at least one carbon atom of the hydrocarbon-based chains may be replaced with an entity chosen from oxygen, nitrogen, and sulphur atoms, and an SO 2 group, and wherein the carbon atoms may be, independently of one another, substituted, for example, with at least one halogen atom; R 0 , R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 11 and R 12 comprising no peroxide bond, nor any diazo or nitroso radicals,
  • R 14 is chosen from a hydrogen atom, linear and branched C 1 -C 10 hydrocarbon-based chains, possibly forming at least one carbon-based ring comprising from 3 to 6 members, and being saturated or unsaturated, wherein at least one carbon atom of the hydrocarbon-based chains may be replaced with an entity chosen from oxygen, nitrogen and sulphur atoms, and an SO 2 group, and wherein the carbon atoms may be, independently of one another, substituted, for example, with at least one halogen atom, R 14 comprising no peroxide bond, nor any diazo or nitroso radicals; provided that said oxygen, nitrogen and sulphur atoms are not linked directly to the nitrogen atom carrying the R 14 radical,
  • R 5 with R 6 may optionally form a carbon-based aromatic ring, such as phenyl,
  • R 13 and R 15 which may be identical or different, are each chosen from C 1 -C 8 alkyl radicals optionally substituted with at least one radical chosen from hydroxyl, C 1 -C 2 alkoxy, and C 2 -C 4 (poly)hydroxyalkoxy, unsubstituted and substituted amino, such as unsubstituted amino and C 1 -C 2 (di)alkylamino, carboxyl, sulphonic, and phenyl radicals which are optionally substituted;
  • X is an anion chosen from organic and inorganic anions.
  • branched hydrocarbon-based chain means a chain which can form at least one carbon-based ring comprising from 3 to 6 members.
  • unsaturated hydrocarbon-based chain means a chain which can comprise at least one double bond and/or at least one triple bond, said hydrocarbon-based chain optionally being able to form aromatic groups.
  • X is an anion chosen from organic and inorganic anions, for example, halides, such as chloride, bromide, fluoride and iodide; hydroxides; sulphates; hydrogen sulphates; (C 1 -C 6 ) alkyl sulphates, such as methyl sulphate and ethyl sulphate; acetates; tartrates; oxalates; (C 1 -C 6 ) alkylsulphonates, such as methylsulphonate; and arylsulphonates which may be substituted with at least one radical chosen from C 1 -C 4 alkyl radicals, such as 4-tolylsulphonate.
  • halides such as chloride, bromide, fluoride and iodide
  • hydroxides such as chloride, bromide, fluoride and iodide
  • hydroxides such as chloride, bromide, fluoride and iodide
  • sulphates hydrogen
  • R 1 , R 2 , and R 3 which may be identical or different, are each chosen from a hydrogen atom; alkoxy, hydroxyl, unsubstituted amino, and acetoxy radicals; linear and branched C 1 -C 4 alkyl radicals substituted with at least one substituent chosen from halogen atoms, hydroxyl, C 1 -C 2 alkoxy, (poly)hydroxyalkoxy, unsubstituted amino, C 1 -C 2 (di)alkylamino, carboxyl and sulphonic radicals; and —NR 16 R 17 groups, wherein R 16 and R 17 , which may be identical or different, are each chosen from a hydrogen atom, methylsulphonyl, carboxyl, carboxamido, and C 1 -C 4 alkyl radicals substituted with at least one substituent chosen from halogen atoms, hydroxyl, C 1 -C 2 alkoxy, unsubstit
  • the asymmetric carbons of said 5-, 6-, 7- and 8-membered heterocycles of formula (II) may, independently of one another, have the configuration (R) or (S).
  • R 1 , R 2 , and R 3 which may be identical or different, are each chosen from a hydrogen atom; a hydroxyl radical; and amino radicals which are optionally mono- or disubstituted; and linear and branched C 1 -C 3 alkyl radicals optionally substituted with at least one radical chosen from hydroxyl, C 1 -C 2 alkoxy, unsubstituted amino, C 1 -C 2 (di)alkylamino, carboxyl, and sulphonic radicals.
  • R 1 , R 2 , and R 3 which may be identical or different, are each chosen from a hydrogen atom; methyl radicals, such as methyl and hydroxymethyl; a hydroxyl radical; and unsubstituted and substituted amino radicals, such as unsubstituted amino, (di)methylamino, methylsulphonylamino, and C 2 -C 4 (poly)hydroxyalkylamino.
  • R 1 is chosen, for example, from a hydrogen atom, and methyl, hydroxyl, and unsubstituted and substituted amino, such as unsubstituted amino, methylamino, dimethylamino, and 2-hydroxyethylamino radicals, and further for example, from a hydrogen atom, a hydroxyl radical, an, unsubstituted amino radical, and a dimethylamino radical, and even further for example from a hydrogen atom and a hydroxyl radical.
  • R 0 is chosen from, for example, a hydrogen atom, and linear and branched C 1 -C 4 alkyl radicals substituted with at least one radical chosen from hydroxyl, methoxy, unsubstituted amino, (di)alkylamino, carboxyl, sulphonyl, amido, and dimethylamido radicals, even further for example, R 0 may be chosen from a hydrogen atom, and carboxyl, amido, dimethylamido, and hydroxymethyl radicals. In another further example, R 0 is a hydrogen atom.
  • Z 1 is chosen from NR 14 and CHR 2 radicals. Further, for example, Z 1 is chosen from CHR 2 radicals.
  • Z 1 in formula (II) is chosen from CH 2 , CHOH, CHNH 2 , and CHN(CH 3 ) 2 , and in a further embodiment, Z 1 in formula (II) is CH 2 .
  • n in formula (II) is 0 or 1. In a further embodiment, n is 0.
  • the radicals R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 and R 12 are, for example, each chosen from a hydrogen atom, and methyl, ethyl, isopropyl, methoxymethyl, hydroxymethyl, 1-carboxymethyl, 1-aminomethyl, 2-carboxyethyl, 2-hydroxyethyl, 3-hydroxypropyl, 1,2-dihydroxyethyl, 1-hydroxy-2-aminoethyl, 2-hydroxy-1-aminoethyl, methoxy, ethoxy, 2-hydroxyethyloxy, 3-aminoethyloxy, unsubstituted amino, methylamino, dimethylamino, and 2-hydroxyethylamino radicals.
  • R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 and R 12 which may be identical or different, are each chosen from, for example, a hydrogen atom, and methyl, hydroxymethyl, 2-hydroxyethyl, 1,2-dihydroxyethyl, methoxy, 2-hydroxyethyloxy, unsubstituted amino, and 2-hydroxyethylamino radicals, and in a further embodiment, R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 and R 12 , which may be identical or different, are each chosen from a hydrogen atom, and methyl, methoxy, and unsubstituted amino radicals.
  • X 1 of formula (III) may be chosen from CR 7 radicals, wherein R 7 is defined as above, and X 2 of formula (III) may be chosen from CR 8 radicals, wherein R 8 is defined as above.
  • R 13 and R 15 are each chosen from C 1 -C 4 alkyl radicals optionally substituted with at least one radical chosen from hydroxyl, C 1 -C 2 alkoxy, unsubstituted amino, C 1 -C 2 (di)alkylamino, carboxyl, sulphonic, and phenyl radicals, and for example, methyl, ethyl, 2-hydroxyethyl, 1-carboxymethyl, 2-carboxyethyl, and 2-sulphonylethyl radicals.
  • R 13 and R 15 which may be identical or different, are each chosen from C 1 -C 3 alkyls optionally substituted with at least one radical chosen from hydroxyl, methoxy, unsubstituted amino, dimethylamino, carboxyl, and sulphonic radicals.
  • R 13 and R 15 which may be identical or different, are each chosen from, for example, methyl, ethyl, 2-hydroxyethyl, and carboxymethyl radicals, and further for example, from a methyl radical.
  • R 14 is chosen from a hydrogen atom, and linear and branched C 1 -C 3 alkyl radicals optionally substituted with at least one radical chosen from hydroxy, methoxy, unsubstituted amino, methylamino, dimethylamino, carboxyl, and sulphonyl radicals.
  • R 14 is chosen from a hydrogen atom, and methyl and 2-hydroxyethyl radicals.
  • Z 2 is chosen from NR 15 with all the above mentioned designations provided for R 15 .
  • R 0 , R 1 , Z 1 , R 3 , R 4 and n are each chosen from the following combinations:
  • R 0 , R 1 , Z 1 , R 3 , R 4 and n are each chosen from the following combinations:
  • the at least one monocationic monoazo dye of formula (I), may be chosen from, for example:
  • the concentration of said at least one monocationic monoazo dye of formula (I) may range, for example, from about 0.001% to about 5% by weight relative to the total weight of the dye composition, and for example, from about 0.05% to about 2% by weight relative to the total weight of the dye composition.
  • the dye composition in accordance with the invention may further comprise at least one additional direct dye which is different from those of formula (I).
  • the at least one additional direct dye may be chosen from neutral, acidic, and cationic nitrobenzene direct dyes; neutral, acidic and cationic azo direct dyes; neutral, acidic and cationic quinone direct dyes, such as anthraquinone direct dyes; azine direct dyes; methine direct dyes; triarylmethane direct dyes; indoamine direct dyes; and natural direct dyes.
  • nitrobenzene direct dyes mention may be made, for example, of the following compounds:
  • azo direct dyes mention may be made of the cationic azo dyes described in patent applications WO 95/15144, WO 95/01772 and EP-714954, the contents of which are incorporated herein by reference.
  • these compounds mention may be made, for example, of the following dyes:
  • azo direct dyes examples include the following dyes, described in the COLOUR INDEX INTERNATIONAL, 3rd edition:
  • azo direct dyes include 1-(4′-aminodiphenylazo)-2-methyl-4-bis( ⁇ -hydroxyethyl)aminobenzene and 4-hydroxy-3-(2-methoxyphenylazo)-1-naphthalenesulphonic acid.
  • examples include the following dyes:
  • azine direct dyes examples include the following compounds:
  • examples include:
  • examples include the following compounds:
  • examples include lawsone, juglone, alizarin, purpurin, carminic acid, kermesic acid, purpurogallin, protocatechaldehyde, indigo, isatin, curcumin, spinulosin, and apigenidin. It is also possible to use extracts or decoctions comprising these natural dyes, such as henna-based poultices or extracts.
  • the at least one additional direct dye is present, for example, in an amount ranging from about 0.001% to about 20% by weight of the total weight of the composition, and, for example, from about 0.005% to about 10% by weight relative to the total weight of the composition.
  • the composition of the invention may further comprise at least one oxidizing agent.
  • oxidizing agent may be any oxidizing agent used conventionally for bleaching human keratin fibres.
  • the oxidizing agent may be chosen from, for example, hydrogen peroxide, urea peroxide, alkali metal bromates, persalts such as perborates and persulphates, peracids and enzymes, among which mention may be made, for example, of peroxidases, 2-electron oxidoreductases such as uricases, and 4-electron oxygenases such as laccases.
  • composition according to the invention when intended for conventional oxidation dyeing, it further comprises at least one oxidation base.
  • oxidation base may be chosen from the oxidation bases conventionally used in oxidation dyeing, for example para-phenylenediamines, bisphenylalkylenediamines, para-aminophenols, ortho-aminophenols, and heterocyclic bases.
  • para-phenylenediamines mention may be made, for example, of para-phenylenediamine, para-tolylenediamine, 2-chloro-para-phenylenediamine, 2,3-dimethyl-para-phenylenediamine, 2,6-dimethyl-para-phenylenediamine, 2,6-diethyl-para-phenylenediamine, 2,5-dimethyl-para-phenylenediamine, N,N-dimethyl-para-phenylenediamine, N,N-diethyl-para-phenylenediamine, N,N-dipropyl-para-phenylenediamine, 4-amino-N,N-diethyl-3-methylaniline, N,N-bis( ⁇ -hydroxyethyl)-para-pheylenediamine, 4-amino-N,N-bis( ⁇ -hydroxyethyl)-2-methylaniline, 4-amino-2-chloro-N,N-
  • para-phenylenediamines mention may also be made, for example, of para-phenylenediamine, para-tolylenediamine, 2-isopropyl-para-phenylenediamine, 2- ⁇ -hydroxyethyl-para-phenylenediamine, 2- ⁇ -hydroxyethyloxy-para-phenylenediamine, 2,6-dimethyl-para-phenylenediamine, 2,6-diethyl-para-phenylenediamine, 2,3-dimethyl-para-phenylenediamine, N,N-bis( ⁇ -hydroxyethyl)-para-phenylenediamine, 2-chloro-para-phenylenediamine, and 2- ⁇ -acetylaminoethyloxy-para-phenylenediamine, and the acid addition salts thereof.
  • bisphenylalkylenediamines mention may be made, for example, of N,N′-bis( ⁇ -hydroxyethyl)-N,N′-bis(4′-aminophenyl)-1,3-diaminopropanol, N,N′-bis( ⁇ -hydroxyethyl)-N,N′-bis(4′-aminophenyl)ethylenediamine, N,N′-bis(4-aminophenyl)tetramethylenediamine, N,N′-bis( ⁇ -hydroxyethyl)-N,N′-bis(4-amino-phenyl)tetramethylenediamine, N,N′-bis(4-methylaminophenyl)tetramethylenediamine, N,N′-bis(ethyl)-N,N′-bis(4′-amino-3′-methylphenyl)ethylenediamine, and 1,8-bis(2,5-diaminophenoxy)
  • para-aminophenol mention may be made, for example, of para-aminophenol, 4-amino-3-methylphenol, 4-amino-3-fluorophenol, 4-amino-3-hydroxymethylphenol, 4-amino-2-methylphenol, 4-amino-2-hydroxymethylphenol, 4-amino-2-methoxymethylphenol, 4-amino-2-aminomethylphenol, 4-amino-2-( ⁇ -hydroxyethylaminomethyl)phenol, and 4-amino-2-fluorophenol, and the acid addition salts thereof.
  • para-aminophenol 4-amino-3-methylphenol, 4-amino-3-fluorophenol, 4-amino-3-hydroxymethylphenol, 4-amino-2-methylphenol, 4-amino-2-hydroxymethylphenol, 4-amino-2-methoxymethylphenol, 4-amino-2-aminomethylphenol, 4-amino-2-( ⁇ -hydroxyethylaminomethyl)phenol, and 4-amino-2-fluorophenol, and the acid addition salts
  • ortho-aminophenols mention may be made, for example, of 2-aminophenol, 2-amino-5-methylphenol, 2-amino-6-methylphenol, and 5-acetamido-2-aminophenol, and the acid addition salts thereof.
  • heterocyclic bases mention may be made, for example, of pyridine derivatives, pyrimidine derivatives, and pyrazole derivatives.
  • pyridine derivatives mention may be made, for example, of compounds described in patents GB 1 026 978 and GB 1 153 196, incorporated herein by reference, such as 2,5-diaminopyridine, 2-(4-methoxyphenyl)amino-3-aminopyridine, 2,3-diamino-6-methoxypyridine, 2-( ⁇ -methoxyethyl)amino-3-amino-6-methoxypyridine, and 3,4-diaminopyridine, and the acid addition salts thereof.
  • pyrimidine derivatives mention may be made, for example, of compounds described, in patents DE 2 359 399; JP 88-169 571; JP 05 163 124; and EP 0 770 375 and patent application WO 96/15765, incorporated herein by reference, such as 2,4,5,6-tetraaminopyrimidine, 4-hydroxy-2,5,6-triaminopyrimidine, 2-hydroxy-4,5,6-triaminopyrimidine, 2,4-dihydroxy-5,6-diaminopyrimidine, and 2,5,6-triaminopyrimidine, and the pyrazolopyrimidine derivatives such as those mentioned in patent application FR-A-2 750 048, and further, for example, pyrazolo[1,5-a]pyrimidine-3,7-diamine; 2,5-dimethylpyrazolo[1,5-a]pyrimidine-3,7-diamine; pyrazolo[1,5-a]pyrimidine-3,5-
  • pyrazole derivatives mention may be made, for example, of compounds described in DE 3 843 892 and DE 4 133 957, and patent applications WO 94/08969, WO 94/08970, FR-A-2 733 749, and DE 195 43 988 incorporated herein by reference, such as 4,5-diamino-1-methylpyrazole, 4,5-diamino-1-( ⁇ -hydroxyethyl)pyrazole, 3,4-diaminopyrazole, 4,5-diamino-1-(4′-chlorobenzyl)pyrazole, 4,5-diamino-1,3-dimethylpyrazole, 4,5-diamino-3-methyl-1-phenylpyrazole, 4,5-diamino-1-methyl-3-phenyl-pyrazole, 4-amino-1,3-dimethyl-5-hydrazinopyrazole, 1-benzyl-4,5-diamino-3-methylpyrazole,
  • composition according to the invention may further comprise at least one coupler conventionally used for the conventional oxidation dyeing of human keratin fibres, such as hair.
  • couplers conventionally used for the conventional oxidation dyeing of human keratin fibres, such as hair.
  • couplers conventionally used for the conventional oxidation dyeing of human keratin fibres, such as hair.
  • couplers for example, of meta-phenylenediamines, meta-aminophenols, meta-diphenols, naphthalene couplers, and heterocyclic couplers.
  • Examples include 2-methyl-5-aminophenol, 5-N-( ⁇ -hydroxyethyl)amino-2-methylphenol, 6-chloro-2-methyl-5-aminophenol, 3-aminophenol, 1,3-dihydroxybenzene, 1,3-dihydroxy-2-methylbenzene, 4-chloro-1,3-dihydroxybenzene, 2,4-diamino-1-( ⁇ -hydroxyethyloxy)benzene, 2-amino-4-( ⁇ -hydroxyethylamino)-1-methoxybenzene, 1,3-diaminobenzene, 1,3-bis(2,4-diaminophenoxy)propane, 3-ureidoaniline, 3-ureido-1-dimethylaminobenzene, sesamol, 1- ⁇ -hydroxyethylamino-3,4-methylenedioxybenzene, ⁇ -naphthol, 2-methyl-1-naphthol, 6-hydroxyindole, 4-hydroxyind
  • the at least one coupler is generally present in an amount, for example, ranging from about 0.001% to about 10% by weight of the total weight of the dye composition, and further, for example, ranging from about 0.005% to about 6% by weight of the total weight of the dye composition.
  • the at least one oxidation base is present, for example, in an amount ranging from about 0.001% to about 10% by weight of the total weight of the dye composition, and further, for example, ranging from about 0.005% to about 6% by weight of the total weight of the dye composition.
  • the acid addition salts that can be used in the context of the dye compositions of the invention for the oxidation bases and the couplers, may be chosen from, for example, hydrochlorides, hydrobromides, sulphates, citrates, succinates, tartrates, lactates, tosylates, benzenesulphonates, phosphates, and acetates.
  • the cosmetically acceptable medium also referred to as dye support, generally consists of water or of a mixture of water and at least one organic solvent in order to solubilize the compounds, which would not be sufficiently water-soluble.
  • organic solvent mention may be made, for example, of C 1 -C 4 lower alkanols such as ethanol and isopropanol; polyols and polyol ethers such as 2-butoxyethanol, propylene glycol, propylene glycol monomethyl ether, diethylene glycol monoethyl ether, and monomethyl ether; and aromatic alcohols such as benzyl alcohol and phenoxyethanol, and mixtures thereof.
  • the at least one organic solvent may be present in an amount ranging, for example, from about 1% to about 40% by weight relative to the total weight of the dye composition, and further, for example, from about 5% to about 30% by weight relative to the total weight of the dye composition.
  • the dye composition in accordance with the invention may further comprise at least one adjuvant chosen from various adjuvants used conventionally in compositions for dyeing hair, such as anionic, cationic, nonionic, amphoteric, and zwitterionic surfactants, and mixtures thereof; anionic, cationic, nonionic, amphoteric, and zwitterionic polymers, and mixtures thereof; inorganic and organic thickeners, and for example, thickeners combining anionic, cationic, non-ionic, and amphoteric polymers; antioxidants; penetration agents; sequestering agents; fragrances; buffers; dispersing agents; conditioners, such as, for example, volatile and non-volatile silicones, which are modified or unmodified; film-forming agents; ceramides; preserving agents; and opacifiers.
  • adjuvants used conventionally in compositions for dyeing hair, such as anionic, cationic, nonionic, amphoteric, and zwitterionic surfactants, and
  • the at least one adjuvant may generally be present in an amount, for example, ranging from about 0.01% to about 20% by weight relative to the total weight of the composition.
  • the pH of the dye composition in accordance with the invention is generally ranging, for example, from about 3 to about 12, and, further for example, from about 5 to about 11. It may be adjusted to the desired value by means of acidifying or basifying agents conventionally used in dyeing keratin fibres, or by using conventional buffer systems.
  • inorganic and organic acids such as hydrochloric acid, orthophosphoric acid, and sulphuric acid
  • carboxylic acids such as acetic acid, tartaric acid, citric acid and lactic acid
  • sulphonic acids for example, of inorganic and organic acids such as hydrochloric acid, orthophosphoric acid, and sulphuric acid
  • carboxylic acids such as acetic acid, tartaric acid, citric acid and lactic acid
  • sulphonic acids such as hydrochloric acid, orthophosphoric acid, and sulphuric acid
  • basifying agents mention may be made, for example, of aqueous ammonia, alkaline carbonates, alkanolamines such as mono-, di- and triethanolamines, and derivatives thereof, sodium hydroxide, and potassium hydroxide, and the compounds of formula (V) below:
  • W is chosen from propylene residues optionally substituted with a radical chosen from hydroxyl and C 1 -C 4 alkyl radicals;
  • R 16 , R 17 , R 18 and R 19 which may be identical or different, are each chosen from a hydrogen atom, C 1 -C 4 alkyl radicals, and C 1 -C 4 hydroxyalkyl radicals.
  • the dye composition according to the invention may be in various forms, such as liquids, creams, gels, or in any other form which is suitable for dyeing human keratin fibres, such as hair.
  • Another aspect of the invention relates to a direct dyeing process, which comprises applying to human keratin fibres, such as hair, a dye composition comprising a dye of formula (I) as defined above; leaving the dye composition standing on the human keratin fibres for a period of time; rinsing the human keratin fibres; and allowing coloured fibres to appear.
  • a direct dyeing process comprises applying to human keratin fibres, such as hair, a dye composition comprising a dye of formula (I) as defined above; leaving the dye composition standing on the human keratin fibres for a period of time; rinsing the human keratin fibres; and allowing coloured fibres to appear.
  • the dye composition comprising the dye of formula (I) may be applied to the fibres in the presence of oxidizing agent, which may cause bleaching of the fibre (direct lightening dyeing).
  • This oxidizing agent may be added to the composition comprising at least one monocationic monoazo dye of formula (I) at the time of use, or directly to the fibre.
  • Another aspect of the invention is an oxidation dyeing process, which comprises applying a dye composition, comprising at least one dye of formula (I), at least one oxidation base and, optionally, at least one coupler, to human keratin fibres, in the presence of at least one oxidizing agent.
  • a dye composition comprising at least one dye of formula (I), at least one oxidation base and, optionally, at least one coupler, to human keratin fibres, in the presence of at least one oxidizing agent.
  • the oxidation base, the coupler, and the oxidizing agent are as defined above.
  • the colour may be developed at acidic, neutral or alkaline pH, and the oxidizing agent may be added to the composition of the invention just at the time of use, or it may be used as an ingredient of an oxidizing composition and applied to the fibres simultaneously with, or sequentially to, the dye composition.
  • the dye composition may be mixed, for example, at the time of use, with a composition comprising, in a medium which is suitable for dyeing, at least one oxidizing agent, such oxidizing agent being present in an amount sufficient to develop a coloration.
  • a composition comprising, in a medium which is suitable for dyeing, at least one oxidizing agent, such oxidizing agent being present in an amount sufficient to develop a coloration.
  • the mixture obtained is then applied to the fibres. After a period ranging from about 3 to about 50 minutes, and for example from about 5 to about 30 minutes, in which the mixture is left on the fibres, the fibres are rinsed, washed with shampoo, rinsed again, and then dried.
  • the oxidizing composition of the present invention may also comprise various adjuvants conventionally used in compositions for dyeing the hair, and as defined above.
  • the pH of the oxidizing composition comprising at least one oxidizing agent is such that, after mixing with the dye composition, the pH of the resulting composition that is applied to the keratin fibres ranges, for example, from about 3 to about 12, and further for example, from about 5 to about 11.
  • the pH may be adjusted to the desired value by means of acidifying or basifying agents conventionally used in dyeing human keratin fibres, such as those defined above.
  • composition which is finally applied to the fibres may be in various forms, such as liquids, creams, gels, or in any other form which is suitable for dyeing human keratin fibres, such as hair.
  • Another aspect of the invention is a multicompartment device or dyeing “kit” in which a first compartment comprises the dye composition of the invention and a second compartment comprises the oxidizing composition.
  • This device may be equipped with a means for applying the desired mixture to the hair, such as the devices described in patent FR-2 586 913.
  • Yet another aspect of the invention is also the novel monocationic monoazo compounds of formula (I) as defined above wherein, in formula (II), n is chosen from 0, 2, and 3.
  • Another aspect of the invention is also the addition of the monocationic monoazo dyes of formula (I), as direct dyes, in a composition for dyeing human keratin fibres, such as hair, as well as a method of preparation thereof.
  • the compounds of the invention may be obtained conventionally from a diazonium salt of 2-aminobenzimidazole.
  • the diazonium preparation is known and described in the literature, and it is carried out in a dilute hydrochloric acid medium.
  • the diazonium salt is then condensed with a compound from the family of the cyclic N,N-dialkyls of anilines, in the presence of an organic base.
  • reaction medium is brought back to basic pH and the azo compound thus formed is isolated.
  • the azo compound thus obtained is quaternized in a solvent at a temperature ranging from 40° C. to 140° C. using an alkylating agent.
  • the 2-aminobenzimidazole derivatives react with sodium nitrite in an acid medium to produce the diazonium reactive intermediate, which, itself, is reacted with a cyclic aniline derivative.
  • the preparations are known and fully described in U.S. Pat. Nos. 5,208,325 and 5,436,323.
  • the protocol is also applied to 2-aminobenzoxazole and 2-aminobenzothiazole derivatives.
  • the corresponding monocationic monoazo dyes of formula (I) may be obtained by applying the same synthetic process to pyridine derivatives and pyridazine derivatives substituted with a cyclic amine comprising 5 to 8 ring members.
  • the pH of the medium was brought back to 7 with an aqueous ammonia solution and the brick-red product formed was filtered off over a No. 4 sintered glass funnel and then washed with 10 times 100 ml of water. After drying, 2 grams of brick-red product were recovered.
  • a dye composition comprising 1.25 grams of dye prepared in the previous example, 13 grams of an aqueous ammonia solution comprising 40% of ammonia by weight, and demineralised water q.s. for 100 grams was mixed at the time of use with a 20-volumes aqueous hydrogen peroxide composition, in a proportion of 1 part dye composition for 1.5 parts oxidizing composition. The mixture obtained was applied to locks of natural and permanent-waved hair comprising 90% white hairs (1 gram of hair per 10 grams of mixture).
  • composition was left to stand on the locks of hair for 35 minutes at ambient temperature.
  • the locks were then rinsed with water, shampooed and then dried.

Abstract

A dye composition for dyeing human keratin fibers, such as hair, comprising at least one monocationic monoazo dye of formula (I)
W1—W2—N═N—W3,
a dyeing process using the composition and certain novel compounds of formula (I).

Description

The present invention relates to a dye composition for dyeing human keratin fibres, such as hair, comprising at least one monocationic monoazo dye. The present invention also relates to the processes for dyeing human keratin fibres, such as hair, using such a composition. The present invention further relates to novel monocationic monoazo compounds.
It is a known practice to dye human keratin fibres, such as hair, with dye compositions containing oxidation dye precursors, generally referred to as oxidation bases, such as ortho- or para-phenylenediamines, ortho- or para-aminophenols, and heterocyclic compounds. These oxidation bases are generally colourless or weakly coloured compounds that, when combined with oxidizing agents, may give rise to coloured compounds by a process of oxidative condensation.
It is also known that the shades obtained with these oxidation bases can be varied by combining them with couplers or colour modifiers. These couplers or colour modifiers may be chosen, for example, from aromatic meta-diamines, meta-aminophenols, meta-diphenols, and certain heterocyclic compounds such as indole compounds.
The variety of molecules used as oxidation bases and couplers can allow for a wide range of colours to be obtained.
This oxidation dyeing process comprises applying to the keratin fibres, oxidation bases or a mixture of oxidation bases and couplers, with an oxidizing agent, for example, aqueous hydrogen peroxide; leaving the mixture to stand on the fibres; and then rinsing the fibres. The colorations which result from the oxidation dyeing process can be permanent, strong, and resistant to external agents, such as light, bad weather, washing, perspiration, and rubbing. The oxidation dyeing process, which is generally applied at basic pH, makes it possible to obtain dyeing and simultaneously lightening of the fibre, making it possible to obtain a final coloration that is lighter than the original colour. Additionally, the lightening of the fibre can have the advantageous effect of giving rise to a uniform colour in the case of grey hair, and, in the case of naturally pigmented hair, of bringing the colour out, i.e., of making it more visible.
It is also a known practice to dye human keratin fibres by direct dyeing. The process conventionally used in direct dyeing comprises applying to the keratin fibres direct dyes, which are coloured, and colouring molecules having an affinity for the fibres, leaving the dyes to stand on the fibres, and then rinsing the fibres.
It is also a known practice, for example, to use nitrobenzene, anthraquinone or nitropyridine direct dyes, azo, xanthene, acridine or azine dyes or triarylmethane dyes.
The resulting colorations from the direct dyes can be chromatic colorations that can, however, be temporary or semi-permanent. The nature of the interactions that bind the direct dyes to the keratin fibre, and their desorption from the surface and/or from the core of the fibre, can be responsible for their weak dyeing capacity, and for their poor resistance to washing or to perspiration. These direct dyes can also be sensitive to light due to the poor resistance of the chromophore to photochemical attacks that lead, over time, to a dulling of the coloration of the hair. Additionally, their sensitivity to light is dependent on whether they are distributed uniformly or in aggregates in the keratin fibre.
Another known practice is to use direct dyes in combination with oxidizing agents. However, the direct dyes can be sensitive to the action of oxidizing agents such as aqueous hydrogen peroxide, and reducing agents such as sodium bisulphite, which generally makes them difficult to use in lightening direct dye compositions based on aqueous hydrogen peroxide and on a basifying agent, or in oxidation dyeing compositions in combination with precursors such as oxidation bases or couplers.
For example, in patent applications FR-1 584 965 and JP-062 711 435, it has been proposed to dye the hair with dye compositions based on direct nitro dyes, and/or on dispersed azo dyes, and on ammoniacal aqueous hydrogen peroxide, by applying to the hair a mixture of said dyes and of said oxidant, prepared just before use. The colorations obtained by this approach, however, can prove to be insufficiently durable, and disappear with shampooing, thus allowing lightening of the hair fibre to appear. By changing over time, such a coloration becomes unaesthetic.
In patent applications JP-53 95693 and JP-55 022638, it has also been proposed to dye the hair with compositions based on cationic direct dyes of the oxazine type and of ammoniacal aqueous hydrogen peroxide, by applying to the hair, in a first step, ammoniacal aqueous hydrogen peroxide, and in a second step, a composition based on the oxazine direct dye. This coloration can be unsatisfactory, due to the fact that it requires a process in which the product needs to be left to stand on the hair for a long time in the two successive steps. If, moreover, an extemporaneous mixture of the oxazine direct dye with ammoniacal aqueous hydrogen peroxide is applied to the hair, then no coloration can be obtained or, at the very least, a virtually nonexistent coloration of the hair fibre can be obtained.
More recently, patent application FR 2 741 798 described dye compositions containing direct dyes comprising at least one quarternized nitrogen atom of the azo or azomethine type, wherein said compositions need to be mixed extemporaneously at basic pH with an oxidizing composition. These compositions make it possible to obtain colorations with homogeneous, durable, and brilliant glints. However, they may not dye keratin fibres with as much strength as oxidation dyeing compositions.
There is therefore a need for chromatic direct dyes which can dye human keratin fibres as strongly as oxidation dyes, and/or can be as stable as oxidation dyes when exposed to light, bad weather, washing, and perspiration. Additionally, there is a need for chromatic direct dyes that can be sufficiently stable in the presence of oxidizing and reducing agents to be able to obtain simultaneously a lightening of the fibre either by using direct lightening compositions comprising them, or by using oxidation dye compositions based on oxidation dye precursors comprising them. There is also a need for direct dyes which can dye human keratin fibres in a wide range of colours, such as chromatic colours, as well as the “fundamental” shades such as blacks and browns.
The present invention therefore relates to a composition for dyeing human keratin fibres, such as hair, comprising, in a cosmetically acceptable medium, at least one monocationic monoazo dye of formula (I) below:
W1—W2—N═N—W3  Formula (I)
wherein:
W1 is chosen from 5-, 6-, 7- and 8-membered heterocycles of formula (II) below:
Figure US06824570-20041130-C00001
W2 is chosen from divalent, aromatic, and carbon-based pyridines and pyridazines of formula (III) below:
Figure US06824570-20041130-C00002
W3 is chosen from cationic heteroaromatic radicals of formula (IV) below:
Figure US06824570-20041130-C00003
wherein in formulae (II), (III) and (IV):
n=0, 1, 2 or 3, provided that when n is greater than or equal to 2, then the R4 radicals may be identical or different,
X1 is chosen from a nitrogen atom and CR7 radicals,
X2 is chosen from a nitrogen atom and CR8 radicals,
Z1 is chosen from CHR2 radicals, oxygen and sulphur atoms, and NR14 radicals,
Z2 is chosen from oxygen and sulphur atoms, and NR15 radicals,
R0, R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11 and R12, which may be identical or different, are each chosen from a hydrogen atom, linear and branched C1-C10 hydrocarbon-based chains, possibly forming at least one carbon-based ring comprising from 3 to 6 members, and being saturated or unsaturated, wherein at least one carbon atom of the hydrocarbon-based chains may be replaced with an entity chosen from oxygen, nitrogen, and sulphur atoms, and an SO2 group, and wherein the carbon atoms may be, independently of one another, substituted, for example, with at least one halogen atom; R0, R1, R2, R3, R4, R5, R6, R7, R8, R9, R11 and R12 comprising no peroxide bond, nor any diazo or nitroso radicals,
R14 is chosen from a hydrogen atom, linear and branched C1-C10 hydrocarbon-based chains, possibly forming at least one carbon-based ring comprising from 3 to 6 members, and being saturated or unsaturated, wherein at least one carbon atom of the hydrocarbon-based chains may be replaced with an entity chosen from oxygen, nitrogen and sulphur atoms, and an SO2 group, and wherein the carbon atoms may be, independently of one another, substituted, for example, with at least one halogen atom, R14 comprising no peroxide bond, nor any diazo or nitroso radicals; provided that said oxygen, nitrogen and sulphur atoms are not linked directly to the nitrogen atom carrying the R14 radical,
R5 with R6 may optionally form a carbon-based aromatic ring, such as phenyl,
R13 and R15, which may be identical or different, are each chosen from C1-C8 alkyl radicals optionally substituted with at least one radical chosen from hydroxyl, C1-C2 alkoxy, and C2-C4 (poly)hydroxyalkoxy, unsubstituted and substituted amino, such as unsubstituted amino and C1-C2 (di)alkylamino, carboxyl, sulphonic, and phenyl radicals which are optionally substituted;
the bond a of the cationic ring of formula (IV) is linked to the azo group of formula (I);
X is an anion chosen from organic and inorganic anions.
According to the invention, when it is indicated that at least one of the carbon atoms of the hydrocarbon-based chains defined for R0, R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12 and R14 may be replaced with an entity chosen from oxygen, nitrogen, and sulphur atoms, and an SO2 group, and/or that the hydrocarbon-based chains are unsaturated, this means that it is possible, by way of example, to make the following transformation:
Figure US06824570-20041130-C00004
As used herein, the expression “branched hydrocarbon-based chain” means a chain which can form at least one carbon-based ring comprising from 3 to 6 members. The expression “unsaturated hydrocarbon-based chain” means a chain which can comprise at least one double bond and/or at least one triple bond, said hydrocarbon-based chain optionally being able to form aromatic groups.
X is an anion chosen from organic and inorganic anions, for example, halides, such as chloride, bromide, fluoride and iodide; hydroxides; sulphates; hydrogen sulphates; (C1-C6) alkyl sulphates, such as methyl sulphate and ethyl sulphate; acetates; tartrates; oxalates; (C1-C6) alkylsulphonates, such as methylsulphonate; and arylsulphonates which may be substituted with at least one radical chosen from C1-C4 alkyl radicals, such as 4-tolylsulphonate.
In a further embodiment of the present invention, R1, R2, and R3, which may be identical or different, are each chosen from a hydrogen atom; alkoxy, hydroxyl, unsubstituted amino, and acetoxy radicals; linear and branched C1-C4 alkyl radicals substituted with at least one substituent chosen from halogen atoms, hydroxyl, C1-C2 alkoxy, (poly)hydroxyalkoxy, unsubstituted amino, C1-C2 (di)alkylamino, carboxyl and sulphonic radicals; and —NR16R17 groups, wherein R16 and R17, which may be identical or different, are each chosen from a hydrogen atom, methylsulphonyl, carboxyl, carboxamido, and C1-C4 alkyl radicals substituted with at least one substituent chosen from halogen atoms, hydroxyl, C1-C2 alkoxy, unsubstituted amino, C1-C2 (di)alkylamino, and carboxyl radicals.
The asymmetric carbons of said 5-, 6-, 7- and 8-membered heterocycles of formula (II) may, independently of one another, have the configuration (R) or (S).
In another embodiment of the present invention, R1, R2, and R3, which may be identical or different, are each chosen from a hydrogen atom; a hydroxyl radical; and amino radicals which are optionally mono- or disubstituted; and linear and branched C1-C3 alkyl radicals optionally substituted with at least one radical chosen from hydroxyl, C1-C2 alkoxy, unsubstituted amino, C1-C2 (di)alkylamino, carboxyl, and sulphonic radicals.
In another embodiment of the present invention, R1, R2, and R3, which may be identical or different, are each chosen from a hydrogen atom; methyl radicals, such as methyl and hydroxymethyl; a hydroxyl radical; and unsubstituted and substituted amino radicals, such as unsubstituted amino, (di)methylamino, methylsulphonylamino, and C2-C4 (poly)hydroxyalkylamino.
According to one embodiment of the invention in formula (II), R1 is chosen, for example, from a hydrogen atom, and methyl, hydroxyl, and unsubstituted and substituted amino, such as unsubstituted amino, methylamino, dimethylamino, and 2-hydroxyethylamino radicals, and further for example, from a hydrogen atom, a hydroxyl radical, an, unsubstituted amino radical, and a dimethylamino radical, and even further for example from a hydrogen atom and a hydroxyl radical.
According to one embodiment of the present invention, in formula (II), R0 is chosen from, for example, a hydrogen atom, and linear and branched C1-C4 alkyl radicals substituted with at least one radical chosen from hydroxyl, methoxy, unsubstituted amino, (di)alkylamino, carboxyl, sulphonyl, amido, and dimethylamido radicals, even further for example, R0 may be chosen from a hydrogen atom, and carboxyl, amido, dimethylamido, and hydroxymethyl radicals. In another further example, R0 is a hydrogen atom.
In one example of the present invention, Z1 is chosen from NR14 and CHR2 radicals. Further, for example, Z1 is chosen from CHR2 radicals.
In another embodiment, Z1 in formula (II) is chosen from CH2, CHOH, CHNH2, and CHN(CH3)2, and in a further embodiment, Z1 in formula (II) is CH2.
According to another embodiment, n in formula (II) is 0 or 1. In a further embodiment, n is 0.
The radicals R5, R6, R7, R8, R9, R10, R11 and R12, which may be identical or different, are, for example, each chosen from a hydrogen atom, and methyl, ethyl, isopropyl, methoxymethyl, hydroxymethyl, 1-carboxymethyl, 1-aminomethyl, 2-carboxyethyl, 2-hydroxyethyl, 3-hydroxypropyl, 1,2-dihydroxyethyl, 1-hydroxy-2-aminoethyl, 2-hydroxy-1-aminoethyl, methoxy, ethoxy, 2-hydroxyethyloxy, 3-aminoethyloxy, unsubstituted amino, methylamino, dimethylamino, and 2-hydroxyethylamino radicals.
In another embodiment, R5, R6, R7, R8, R9, R10, R11 and R12, which may be identical or different, are each chosen from, for example, a hydrogen atom, and methyl, hydroxymethyl, 2-hydroxyethyl, 1,2-dihydroxyethyl, methoxy, 2-hydroxyethyloxy, unsubstituted amino, and 2-hydroxyethylamino radicals, and in a further embodiment, R5, R6, R7, R8, R9, R10, R11 and R12, which may be identical or different, are each chosen from a hydrogen atom, and methyl, methoxy, and unsubstituted amino radicals.
According to another embodiment of the invention, X1 of formula (III) may be chosen from CR7 radicals, wherein R7 is defined as above, and X2 of formula (III) may be chosen from CR8 radicals, wherein R8 is defined as above.
According to another embodiment of the invention, R13 and R15, which may be identical or different, are each chosen from C1-C4 alkyl radicals optionally substituted with at least one radical chosen from hydroxyl, C1-C2 alkoxy, unsubstituted amino, C1-C2 (di)alkylamino, carboxyl, sulphonic, and phenyl radicals, and for example, methyl, ethyl, 2-hydroxyethyl, 1-carboxymethyl, 2-carboxyethyl, and 2-sulphonylethyl radicals.
In one embodiment, R13 and R15, which may be identical or different, are each chosen from C1-C3 alkyls optionally substituted with at least one radical chosen from hydroxyl, methoxy, unsubstituted amino, dimethylamino, carboxyl, and sulphonic radicals.
In another embodiment, R13 and R15, which may be identical or different, are each chosen from, for example, methyl, ethyl, 2-hydroxyethyl, and carboxymethyl radicals, and further for example, from a methyl radical.
According to an embodiment of the invention, R14 is chosen from a hydrogen atom, and linear and branched C1-C3 alkyl radicals optionally substituted with at least one radical chosen from hydroxy, methoxy, unsubstituted amino, methylamino, dimethylamino, carboxyl, and sulphonyl radicals.
According to another embodiment, R14 is chosen from a hydrogen atom, and methyl and 2-hydroxyethyl radicals.
According to another embodiment, Z2 is chosen from NR15 with all the above mentioned designations provided for R15.
According to another embodiment, R0, R1, Z1, R3, R4 and n are each chosen from the following combinations:
R0 R1 Z1 R3 R4 n
H H CH2 H H 0, 1, 2, 3
H H N CH3 H H 0 or 1
H H N—CH2—CH2—OH H H 0 or 1
CH3 CH3 CH2 H H 0 or 1
COOH H CH2 H H 0, 1, 2
COOH OH CH2 H H 0 or 1
COOH H CH—OH H H 0
COOH H CH—COOH H H 0
CH2—OH OH CH—OH H H 0
CH2—O CH3 H CH2 CH2—O CH3 H 0
CONH2 H CH2 H H 0, 1, 2
CONH2 OH CH2 H H 0 or 1
CON(CH3)2 H CH2 H H 0, 1, 2
CON(CH3)2 OH CH2 H H 0 or 1
CH2OH H CH2 H H 0 or 1
CH2OH OH CH2 H H 0 or 1
CH2OH H CH2 CH2OH H 0
H OH CH2 H H 0 or 1
H OH CH—OH H H 0 or 1
H NH2 CH2 H H 0 or 1
H NH CH3 CH2 H H 0 or 1
H N (CH3)2 CH2 H H 0 or 1
H OH CH—NH2 H H 0 or 1
H OH CH—NH CH3 H H 0 or 1
H OH CH—NH—CH2—CH—OH H H 0 or 1
H OH CH—OH OH OH 2
CH3 H CH2 H H 1
H H CH—OH H H 1
CH3 H CH2 H CH3 1
CH2—NH2 H CH2 H CH3 1
CH3 H CH—NH2 H H 1
H CH2—OH CH2 H H 1
H H CH—CH—OH H H 1
H CO—NH2 CH2 H H 1
H COOH CH2 H H 1
H H CH2—COOH H H 1
H H CH2 H H 1
H H CH-N(CH3)2 H H 1
In a further embodiment, R0, R1, Z1, R3, R4 and n are each chosen from the following combinations:
R0 R1 Z1 R3 R4 n
COOH H CH2 H H 0
COOH OH CH2 H H 0
CON(CH3)2 H CH2 H H 0
CONH2 H CH2 H H 0
CH2OH H CH2 H H 0
CH2OH OH CH2 H H 0
H OH CH2 H H 0
H NH2 CH2 H H 0
H NH(CH3)2 CH2 H H 0
The at least one monocationic monoazo dye of formula (I), may be chosen from, for example:
1,3-dimethyl-2-[4-(pyrrolidin-1-yl)phenylazo]benzimidazol-1-ium,
1,3-dimethyl-2-[4-(3-hydroxypyrrolidin-1-yl)phenylazo]benzimidazol-1-ium,
1,3-dimethyl-2-[4-(2-carboxypyrrolidin-1-yl)phenylazo]benzimidazol-1-ium,
1,3-dimethyl-2-[4-(3-aminopyrrolidin-1-yl)phenylazo]benzimidazol-1-ium,
1,3-dimethyl-2-[4-(2-carboxy-3-hydroxypyrrolidin-1-yl)phenylazo]benzimidazol-1-ium,
1,3-dimethyl-2-[4-(2-carboxamidopyrrolidin-1-yl)phenylazo]benzimidazol-1-ium,
1,3-dimethyl-2-[4-(2-hydroxymethylpyrrolidin-1-yl)phenylazo]benzimidazol-1-ium,
1,3-dimethyl-2-[4-(2-carboxy-4-hydroxypyrrolidin-1-yl)phenylazo]benzimidazol-1-ium,
1,3-dimethyl-2-[4-(piperidin-1-yl)phenylazo]benzimidazol-1-ium,
1,3-dimethyl-2-[4-(3-hydroxypiperidin-1-yl)phenylazo]benzimidazol-1-ium,
1,3-dimethyl-2-[4-(3-hydroxymethylpiperidin-1-yl)phenylazo]benzimidazol-1-ium,
1,3-dimethyl-2-[4-(3-carboxypiperidin-1-yl)phenylazo]benzimidazol-1-ium,
1,3-dimethyl-2-[4-(2-carboxypiperidin-1-yl)phenylazo]benzimidazol-1-ium,
1,3-dimethyl-2-[4-(piperazin-1-yl)phenylazo]benzimidazol-1-ium,
1,3-dimethyl-2-[4-(homopiperazin-1-yl)phenylazo]benzimidazol-1-ium,
5-amino-1,3-dimethyl-2-[4-(pyrrolidin-1-yl)phenylazo]benzimidazol-1-ium,
5-amino-1,3-dimethyl-2-[4-(3-hydroxypyrrolidin-1-yl)phenylazo]benzimidazol-1-ium,
5-amino-1,3-dimethyl-2-[4-(2-carboxypyrrolidin-1-yl)phenylazo]benzimidazol-1-ium,
5-amino-1,3--dimethyl-2-[4-(3-aminopyrrolidin-1-yl)phenylazo]benzimidazol-1-ium,
5-amino-1,3-dimethyl-2-[4-(2-carboxy-3-hydroxypyrrolidin-1-yl)phenylazo]benzimidazol-1-ium,
5-amino-1,3-dimethyl-2-[4-(2-carboxamidopyrrolidin-1-yl)phenylazo]benzimidazol-1-ium,
5-amino-1,3-dimethyl-2-[4-(2-hydroxymethylpyrrolidin-1-yl)phenylazo]benzimidazol-1-ium,
5-amino-1,3-dimethyl-2-[4-(2-carboxy-4-hydroxypyrrolidin-1-yl)phenylazo]benzimidazol-1-ium,
5-amino-1,3-dimethyl-2-[4-(piperidin-1-yl)phenylazo]benzimidazol-1-ium,
5-amino-1,3-dimethyl-2-[4-(3-hydroxypiperidin-1-yl)phenylazo]benzimidazol-1-ium,
5-amino-1,3-dimethyl-2-[4-(3-hydroxymethylpiperidin-1-yl)phenylazo]benzimidazol-1-ium,
5-amino-1,3-dimethyl-2-[4-(3-carboxypiperidin-1-yl)phenylazo]benzimidazol-1-ium,
5-amino-1,3-dimethyl-2-[4-(2-carboxypiperidin-1-yl)phenylazo]benzimidazol-1-ium,
5-amino-1,3-dimethyl-2-[4-(piperazin-1-yl)phenylazo]benzimidazol-1-ium,
5-amino-1,3-dimethyl-2-[4-(homopiperazin-1-yl)phenylazo]benzimidazol-1-ium,
5-dimethylamino-1,3-dimethyl-2-[4-(pyrrolidin-1-yl)phenylazo]benzimidazol-1-ium,
5-dimethylamino-1,3-dimethyl-2-[4-(3-hydroxypyrrolidin-1-yl)phenylazo]benzimidazol-1-ium,
5-dimethylamino-1,3-dimethyl-2-[4-(2-carboxypyrrolidin-1-yl)phenylazo]benzimidazol-1-ium,
5-dimethylamino-1,3-dimethyl-2-[4-(3-aminopyrrolidin-1-yl)phenylazo]benzimidazol-1-ium,
5-dimethylamino-1,3-dimethyl-2-[4-(2-carboxy-3-hydroxypyrrolidin-1-yl)phenylazo]benzimidazol-1-ium,
5-dimethylamino-1,3-dimethyl-2-[4-(2-carboxamidopyrrolidin-1-yl)phenylazo]benzimidazol-1-ium,
5-dimethylamino-1,3-dimethyl-2-[4-(2-hydroxymethylpyrrolidin-1-yl)phenylazo]benzimidazol-1-ium,
5-dimethylamino-1,3-dimethyl-2-[4-(2-carboxy-4-hydroxypyrrolidin-1-yl)phenylazo]benzimidazol-1-ium,
5-dimethylamino-1,3-dimethyl-2-[4-(piperidin-1-yl)phenylazo]benzimidazol-1-ium,
5-dimethylamino-1,3-dimethyl-2-[4-(3-hydroxypiperidin-1-yl)phenylazo]benzimidazol-1-ium,
5-dimethylamino-1,3-dimethyl-2-[4-(3-hydroxymethylpiperidin-1-yl)phenylazo]benzimidazol-1-ium,
5-dimethylamino-1,3-dimethyl-2-[4-(3-carboxypiperidin-1-yl)phenylazo]benzimidazol-1-ium,
5-dimethylamino-1,3-dimethyl-2-[4-(2-carboxypiperidin-1-yl)phenylazo]benzimidazol-1-ium,
5-dimethylamino-1,3-dimethyl-2-[4-(piperazin-1-yl)phenylazo]benzimidazol-1-ium, and
5-dimethylamino-1,3-dimethyl-2-[4-(homopiperazin-1-yl)phenylazo]benzimidazol-1-ium.
The concentration of said at least one monocationic monoazo dye of formula (I) may range, for example, from about 0.001% to about 5% by weight relative to the total weight of the dye composition, and for example, from about 0.05% to about 2% by weight relative to the total weight of the dye composition.
The dye composition in accordance with the invention may further comprise at least one additional direct dye which is different from those of formula (I). For example, the at least one additional direct dye may be chosen from neutral, acidic, and cationic nitrobenzene direct dyes; neutral, acidic and cationic azo direct dyes; neutral, acidic and cationic quinone direct dyes, such as anthraquinone direct dyes; azine direct dyes; methine direct dyes; triarylmethane direct dyes; indoamine direct dyes; and natural direct dyes.
Among nitrobenzene direct dyes, mention may be made, for example, of the following compounds:
1,4-diamino-2-nitrobenzene
1-amino-2-nitro-4-β-hydroxyethylaminobenzene
1-amino-2-nitro-4-bis(β-hydroxyethyl)aminobenzene
1,4-bis(β-hydroxyethylamino)-2-nitrobenzene
1-β-hydroxyethylamino-2-nitro-4-bis(β-hydroxyethylamino)benzene
1-β-hydroxyethylamino-2-nitro-4-aminobenzene
1-β-hydroxyethylamino-2-nitro-4-(ethyl)(β-hydroxyethyl)aminobenzene
1-amino-3-methyl-4-β-hydroxyethylamino-6-nitrobenzene
1-amino-2-nitro-4-β-hydroxyethylamino-5-chlorobenzene
1,2-diamino-4-nitrobenzene
1-amino-2-β-hydroxyethylamino-5-nitrobenzene
1,2-bis(β-hydroxyethylamino)-4-nitrobenzene
1-amino-2-tris(hydroxymethyl)methylamino-5-nitrobenzene
1-hydroxy-2-amino-5-nitrobenzene
1-hydroxy-2-amino-4-nitrobenzene
1-hydroxy-3-nitro-4-aminobenzene
1-hydroxy-2-amino-4,6-dinitrobenzene
1-β-hydroxyethyloxy-2-β-hydroxyethylamino-5-nitrobenzene
1-methoxy-2-β-hydroxyethylamino-5-nitrobenzene
1-β-hydroxyethyloxy-3-methylamino-4-nitrobenzene
1-β,γ-dihydroxypropyloxy-3-methylamino-4-nitrobenzene
1-β-hydroxyethylamino-4-β,γ-dihydroxypropyloxy-2-nitrobenzene
1-β,γ-dihydroxypropylamino-4-trifluoromethyl-2-nitrobenzene
1-β-hydroxyethylamino-4-trifluoromethyl-2-nitrobenzene
1-β-hydroxyethylamino-3-methyl-2-nitrobenzene
1-β-aminoethylamino-5-methoxy-2-nitrobenzene
1-hydroxy-2-chloro-6-ethylamino-4-nitrobenzene
1-hydroxy-2-chloro-6-amino-4-nitrobenzene
1-hydroxy-6-bis(β-hydroxyethyl)amino-3-nitrobenzene
1-β-hydroxyethylamino-2-nitrobenzene
1-hydroxy-4-β-hydroxyethylamino-3-nitrobenzene.
Among the azo direct dyes, mention may be made of the cationic azo dyes described in patent applications WO 95/15144, WO 95/01772 and EP-714954, the contents of which are incorporated herein by reference. Among these compounds, mention may be made, for example, of the following dyes:
1,3-dimethyl-2-[[4-(dimethylamino)phenyl]azo]-1H-imidazolium chloride,
1,3-dimethyl-2-[(4-aminophenyl)azo]-1H-imidazolium chloride, and
1-methyl-4-[(methylphenylhydrazono)methyl]pyridinium methyl sulphate.
Among the azo direct dyes, examples include the following dyes, described in the COLOUR INDEX INTERNATIONAL, 3rd edition:
Disperse Red 17
Acid Yellow 9
Acid Black 1
Basic Red 22
Basic Red 76
Basic Yellow 57
Basic Brown 16
Acid Yellow 36
Acid Orange 7
Acid Red 33
Acid Red 35
Basic Brown 17
Acid Yellow 23
Acid Orange 24
Disperse Black 9.
Further examples of azo direct dyes include 1-(4′-aminodiphenylazo)-2-methyl-4-bis(β-hydroxyethyl)aminobenzene and 4-hydroxy-3-(2-methoxyphenylazo)-1-naphthalenesulphonic acid.
Among the quinone direct dyes, examples include the following dyes:
Disperse Red 15
Solvent Violet 13
Acid Violet 43
Disperse Violet 1
Disperse Violet 4
Disperse Blue 1
Disperse Violet 8
Disperse Blue 3
Disperse Red 11
Acid Blue 62
Disperse Blue 7
Basic Blue 22
Disperse Violet 15
Basic Blue 99
and further examples include the following compounds:
1-N-methylmorpholiniumpropylamino-4-hydroxyanthraquinone
1-aminopropylamino-4-methylaminoanthraquinone
1-aminopropylaminoanthraquinone
5-β-hydroxyethyl-1,4-diaminoanthraquinone
2-aminoethylaminoanthraquinone
1,4-bis(β,γ-dihydroxypropylamino)anthraquinone.
Among the azine direct dyes, examples include the following compounds:
Basic Blue 17
Basic Red 2.
Among the triarylmethane direct dyes, examples include:
Basic Green 1
Acid Blue 9
Basic Violet 3
Basic Violet 14
Basic Blue 7
Acid Violet 49
Basic Blue 26
Acid Blue 7.
Among the indoamine direct dyes, examples include the following compounds:
2-β-hydroxyethylamino-5-[bis(β-4′-hydroxyethyl )amino]anilino-1,4-benzoquinone
2-β-hydroxyethylamino-5-(2′-methoxy-4′-amino)anilino-1,4-benzoquinone
3-N-(2′-chloro-4′-hydroxy)phenylacetylamino-6-methoxy-1,4-benzoquinoneimine
3-N-(3′-chloro-4′-methylamino)phenylureido-6-methyl-1,4-benzoquinoneimine
3-[4′-N-(ethylcarbamylmethyl)amino]phenylureido-6-methyl-1,4-benzoquinoneimine.
Among the natural direct dyes, examples include lawsone, juglone, alizarin, purpurin, carminic acid, kermesic acid, purpurogallin, protocatechaldehyde, indigo, isatin, curcumin, spinulosin, and apigenidin. It is also possible to use extracts or decoctions comprising these natural dyes, such as henna-based poultices or extracts.
The at least one additional direct dye is present, for example, in an amount ranging from about 0.001% to about 20% by weight of the total weight of the composition, and, for example, from about 0.005% to about 10% by weight relative to the total weight of the composition.
The composition of the invention may further comprise at least one oxidizing agent. Such oxidizing agent may be any oxidizing agent used conventionally for bleaching human keratin fibres. The oxidizing agent may be chosen from, for example, hydrogen peroxide, urea peroxide, alkali metal bromates, persalts such as perborates and persulphates, peracids and enzymes, among which mention may be made, for example, of peroxidases, 2-electron oxidoreductases such as uricases, and 4-electron oxygenases such as laccases.
When the composition according to the invention is intended for conventional oxidation dyeing, it further comprises at least one oxidation base. Such oxidation base may be chosen from the oxidation bases conventionally used in oxidation dyeing, for example para-phenylenediamines, bisphenylalkylenediamines, para-aminophenols, ortho-aminophenols, and heterocyclic bases.
Among the para-phenylenediamines, mention may be made, for example, of para-phenylenediamine, para-tolylenediamine, 2-chloro-para-phenylenediamine, 2,3-dimethyl-para-phenylenediamine, 2,6-dimethyl-para-phenylenediamine, 2,6-diethyl-para-phenylenediamine, 2,5-dimethyl-para-phenylenediamine, N,N-dimethyl-para-phenylenediamine, N,N-diethyl-para-phenylenediamine, N,N-dipropyl-para-phenylenediamine, 4-amino-N,N-diethyl-3-methylaniline, N,N-bis(β-hydroxyethyl)-para-pheylenediamine, 4-amino-N,N-bis(β-hydroxyethyl)-2-methylaniline, 4-amino-2-chloro-N,N-bis(β-hydroxyethyl)aniline, 2-β-hydroxyethyl-para-phenylenediamine, 2-fluoro-para-phenylenediamine, 2-isopropyl-para-phenylenediamine, N-(β-hydroxypropyl)-para-phenylenediamine, 2-hydroxymethyl-para-phenylenediamine, N,N-dimethyl-3-methyl-para-phenylenediamine, N,N-(ethyl-β-hydroxyethyl)-para-phenylenediamine, N-(-β,γdihydroxypropyl)-para-phenylenediamine, N-(4′-aminophenyl)-para-phenylenediamine, N-phenyl-para-phenylenediamine, 2-β-hydroxyethyloxy-para-phenylenediamine, 2-β-acetylaminoethyloxy-para-phenylenediamine, N-(β-methoxyethyl)-para-phenylenediamine, 4-aminophenylpyrrolidone, 2-thienyl-para-phenylenediamine, and 5-amino-2-β-hydroxyethylaminotoluene, and the acid addition salts thereof.
Among the para-phenylenediamines, mention may also be made, for example, of para-phenylenediamine, para-tolylenediamine, 2-isopropyl-para-phenylenediamine, 2-β-hydroxyethyl-para-phenylenediamine, 2-β-hydroxyethyloxy-para-phenylenediamine, 2,6-dimethyl-para-phenylenediamine, 2,6-diethyl-para-phenylenediamine, 2,3-dimethyl-para-phenylenediamine, N,N-bis(β-hydroxyethyl)-para-phenylenediamine, 2-chloro-para-phenylenediamine, and 2-β-acetylaminoethyloxy-para-phenylenediamine, and the acid addition salts thereof.
Among the bisphenylalkylenediamines, mention may be made, for example, of N,N′-bis(β-hydroxyethyl)-N,N′-bis(4′-aminophenyl)-1,3-diaminopropanol, N,N′-bis(β-hydroxyethyl)-N,N′-bis(4′-aminophenyl)ethylenediamine, N,N′-bis(4-aminophenyl)tetramethylenediamine, N,N′-bis(β-hydroxyethyl)-N,N′-bis(4-amino-phenyl)tetramethylenediamine, N,N′-bis(4-methylaminophenyl)tetramethylenediamine, N,N′-bis(ethyl)-N,N′-bis(4′-amino-3′-methylphenyl)ethylenediamine, and 1,8-bis(2,5-diaminophenoxy)-3,6-dioxaoctane, and the acid addition salts thereof.
Among the para-aminophenols, mention may be made, for example, of para-aminophenol, 4-amino-3-methylphenol, 4-amino-3-fluorophenol, 4-amino-3-hydroxymethylphenol, 4-amino-2-methylphenol, 4-amino-2-hydroxymethylphenol, 4-amino-2-methoxymethylphenol, 4-amino-2-aminomethylphenol, 4-amino-2-(β-hydroxyethylaminomethyl)phenol, and 4-amino-2-fluorophenol, and the acid addition salts thereof.
Among the ortho-aminophenols, mention may be made, for example, of 2-aminophenol, 2-amino-5-methylphenol, 2-amino-6-methylphenol, and 5-acetamido-2-aminophenol, and the acid addition salts thereof.
Among the heterocyclic bases, mention may be made, for example, of pyridine derivatives, pyrimidine derivatives, and pyrazole derivatives.
Among the pyridine derivatives, mention may be made, for example, of compounds described in patents GB 1 026 978 and GB 1 153 196, incorporated herein by reference, such as 2,5-diaminopyridine, 2-(4-methoxyphenyl)amino-3-aminopyridine, 2,3-diamino-6-methoxypyridine, 2-(β-methoxyethyl)amino-3-amino-6-methoxypyridine, and 3,4-diaminopyridine, and the acid addition salts thereof.
Among the pyrimidine derivatives, mention may be made, for example, of compounds described, in patents DE 2 359 399; JP 88-169 571; JP 05 163 124; and EP 0 770 375 and patent application WO 96/15765, incorporated herein by reference, such as 2,4,5,6-tetraaminopyrimidine, 4-hydroxy-2,5,6-triaminopyrimidine, 2-hydroxy-4,5,6-triaminopyrimidine, 2,4-dihydroxy-5,6-diaminopyrimidine, and 2,5,6-triaminopyrimidine, and the pyrazolopyrimidine derivatives such as those mentioned in patent application FR-A-2 750 048, and further, for example, pyrazolo[1,5-a]pyrimidine-3,7-diamine; 2,5-dimethylpyrazolo[1,5-a]pyrimidine-3,7-diamine; pyrazolo[1,5-a]pyrimidine-3,5-diamine; 2,7-dimethylpyrazolo[1,5-a]pyrimidine-3,5-diamine; 3-aminopyrazolo[1,5-a]pyrimidin-7-ol; 3-aminopyrazolo[1,5-a]pyrimidin-5-ol; 2-(3-aminopyrazolo[1,5-a]pyrimidin-7-ylamino)ethanol, 2-(7-aminopyrazolo[1,5-a]pyrimidin-3-ylamino)ethanol, 2-[(3-aminopyrazolo[1,5-a]pyrimidin-7-yl)(2-hydroxyethyl)amino]ethanol, 2-[(7-aminopyrazolo[1,5-a]pyrimidin-3-yl)(2-hydroxyethyl)amino]ethanol, 5,6-dimethylpyrazolo[1,5-a]pyrimidine-3,7-diamine, 2,6-dimethylpyrazolo[1,5-a]pyrimidine-3,7-diamine, 2,5,N7,N7-tetramethylpyrazolo[1,5-a]pyrimidine-3,7-diamine, and 3-amino-5-methyl-7-imidazolylpropylaminopyrazolo[1,5-a]pyrimidine, and the acid addition salts thereof, and the tautomeric forms thereof, when a tautomeric equilibrium exists.
Among the pyrazole derivatives, mention may be made, for example, of compounds described in DE 3 843 892 and DE 4 133 957, and patent applications WO 94/08969, WO 94/08970, FR-A-2 733 749, and DE 195 43 988 incorporated herein by reference, such as 4,5-diamino-1-methylpyrazole, 4,5-diamino-1-(β-hydroxyethyl)pyrazole, 3,4-diaminopyrazole, 4,5-diamino-1-(4′-chlorobenzyl)pyrazole, 4,5-diamino-1,3-dimethylpyrazole, 4,5-diamino-3-methyl-1-phenylpyrazole, 4,5-diamino-1-methyl-3-phenyl-pyrazole, 4-amino-1,3-dimethyl-5-hydrazinopyrazole, 1-benzyl-4,5-diamino-3-methylpyrazole, 4,5-diamino-3-tert-butyl-1-methylpyrazole, 4,5-diamino-1-tert-butyl-3-methylpyrazole, 4,5-diamino-1-(β-hydroxyethyl)-3-methylpyrazole, 4,5-diamino-1-ethyl-3-methylpyrazole, 4,5-diamino-1-ethyl-3-(4′-methoxyphenyl)pyrazole, 4,5-diamino-1-ethyl-3-hydroxymethylpyrazole, 4,5-diamino-3-hydroxymethyl-1-methylpyrazole, 4,5-diamino-3-hydroxymethyl-1-isopropylpyrazole, 4,5-diamino-3-methyl-1-isopropylpyrazole, 4-amino-5-(2′-aminoethyl)amino-1,3-dimethylpyrazole, 3,4,5-triaminopyrazole, 1-methyl-3,4,5-triaminopyrazole, 3,5-diamino-1-methyl-4-methylaminopyrazole, and 3,5-diamino-4-(β-hydroxyethyl)amino-1-methylpyrazole, and the acid addition salts thereof.
The composition according to the invention may further comprise at least one coupler conventionally used for the conventional oxidation dyeing of human keratin fibres, such as hair. Among those conventionally used couplers, mention may be made, for example, of meta-phenylenediamines, meta-aminophenols, meta-diphenols, naphthalene couplers, and heterocyclic couplers.
Examples include 2-methyl-5-aminophenol, 5-N-(β-hydroxyethyl)amino-2-methylphenol, 6-chloro-2-methyl-5-aminophenol, 3-aminophenol, 1,3-dihydroxybenzene, 1,3-dihydroxy-2-methylbenzene, 4-chloro-1,3-dihydroxybenzene, 2,4-diamino-1-(β-hydroxyethyloxy)benzene, 2-amino-4-(β-hydroxyethylamino)-1-methoxybenzene, 1,3-diaminobenzene, 1,3-bis(2,4-diaminophenoxy)propane, 3-ureidoaniline, 3-ureido-1-dimethylaminobenzene, sesamol, 1-β-hydroxyethylamino-3,4-methylenedioxybenzene, α-naphthol, 2-methyl-1-naphthol, 6-hydroxyindole, 4-hydroxyindole, 4-hydroxy-N-methylindole, 2-amino-3-hydroxypyridine, 6-hydroxybenzomorpholine, 3,5-diamino-2,6-dimethoxypyridine, 1-N-(β-hydroxyethyl)amino-3,4-methylenedioxybenzene, and 2,6-bis(β-hydroxyethylamino)toluene, and the acid addition salts thereof.
In the composition of the present invention, the at least one coupler is generally present in an amount, for example, ranging from about 0.001% to about 10% by weight of the total weight of the dye composition, and further, for example, ranging from about 0.005% to about 6% by weight of the total weight of the dye composition. The at least one oxidation base is present, for example, in an amount ranging from about 0.001% to about 10% by weight of the total weight of the dye composition, and further, for example, ranging from about 0.005% to about 6% by weight of the total weight of the dye composition.
In general, the acid addition salts that can be used in the context of the dye compositions of the invention for the oxidation bases and the couplers, may be chosen from, for example, hydrochlorides, hydrobromides, sulphates, citrates, succinates, tartrates, lactates, tosylates, benzenesulphonates, phosphates, and acetates.
The cosmetically acceptable medium, also referred to as dye support, generally consists of water or of a mixture of water and at least one organic solvent in order to solubilize the compounds, which would not be sufficiently water-soluble. For the organic solvent, mention may be made, for example, of C1-C4 lower alkanols such as ethanol and isopropanol; polyols and polyol ethers such as 2-butoxyethanol, propylene glycol, propylene glycol monomethyl ether, diethylene glycol monoethyl ether, and monomethyl ether; and aromatic alcohols such as benzyl alcohol and phenoxyethanol, and mixtures thereof.
The at least one organic solvent may be present in an amount ranging, for example, from about 1% to about 40% by weight relative to the total weight of the dye composition, and further, for example, from about 5% to about 30% by weight relative to the total weight of the dye composition.
The dye composition in accordance with the invention may further comprise at least one adjuvant chosen from various adjuvants used conventionally in compositions for dyeing hair, such as anionic, cationic, nonionic, amphoteric, and zwitterionic surfactants, and mixtures thereof; anionic, cationic, nonionic, amphoteric, and zwitterionic polymers, and mixtures thereof; inorganic and organic thickeners, and for example, thickeners combining anionic, cationic, non-ionic, and amphoteric polymers; antioxidants; penetration agents; sequestering agents; fragrances; buffers; dispersing agents; conditioners, such as, for example, volatile and non-volatile silicones, which are modified or unmodified; film-forming agents; ceramides; preserving agents; and opacifiers.
The at least one adjuvant may generally be present in an amount, for example, ranging from about 0.01% to about 20% by weight relative to the total weight of the composition.
Of course, those skilled in the art will take care to select these optional additional compounds such that the advantageous properties intrinsically associated with the dye composition in accordance with the invention are not, or are not substantially, adversely affected by the addition envisaged.
The pH of the dye composition in accordance with the invention is generally ranging, for example, from about 3 to about 12, and, further for example, from about 5 to about 11. It may be adjusted to the desired value by means of acidifying or basifying agents conventionally used in dyeing keratin fibres, or by using conventional buffer systems.
Among the acidifying agents, mention may be made, for example, of inorganic and organic acids such as hydrochloric acid, orthophosphoric acid, and sulphuric acid; carboxylic acids such as acetic acid, tartaric acid, citric acid and lactic acid; and sulphonic acids.
Among the basifying agents, mention may be made, for example, of aqueous ammonia, alkaline carbonates, alkanolamines such as mono-, di- and triethanolamines, and derivatives thereof, sodium hydroxide, and potassium hydroxide, and the compounds of formula (V) below:
Figure US06824570-20041130-C00005
wherein:
W is chosen from propylene residues optionally substituted with a radical chosen from hydroxyl and C1-C4 alkyl radicals; R16, R17, R18 and R19, which may be identical or different, are each chosen from a hydrogen atom, C1-C4 alkyl radicals, and C1-C4 hydroxyalkyl radicals.
The dye composition according to the invention may be in various forms, such as liquids, creams, gels, or in any other form which is suitable for dyeing human keratin fibres, such as hair.
Another aspect of the invention relates to a direct dyeing process, which comprises applying to human keratin fibres, such as hair, a dye composition comprising a dye of formula (I) as defined above; leaving the dye composition standing on the human keratin fibres for a period of time; rinsing the human keratin fibres; and allowing coloured fibres to appear.
In one embodiment, the dye composition comprising the dye of formula (I) may be applied to the fibres in the presence of oxidizing agent, which may cause bleaching of the fibre (direct lightening dyeing). This oxidizing agent may be added to the composition comprising at least one monocationic monoazo dye of formula (I) at the time of use, or directly to the fibre.
Another aspect of the invention is an oxidation dyeing process, which comprises applying a dye composition, comprising at least one dye of formula (I), at least one oxidation base and, optionally, at least one coupler, to human keratin fibres, in the presence of at least one oxidizing agent. The oxidation base, the coupler, and the oxidizing agent are as defined above.
The colour may be developed at acidic, neutral or alkaline pH, and the oxidizing agent may be added to the composition of the invention just at the time of use, or it may be used as an ingredient of an oxidizing composition and applied to the fibres simultaneously with, or sequentially to, the dye composition.
In the case of oxidation dyeing or of direct dyeing, the dye composition may be mixed, for example, at the time of use, with a composition comprising, in a medium which is suitable for dyeing, at least one oxidizing agent, such oxidizing agent being present in an amount sufficient to develop a coloration. The mixture obtained is then applied to the fibres. After a period ranging from about 3 to about 50 minutes, and for example from about 5 to about 30 minutes, in which the mixture is left on the fibres, the fibres are rinsed, washed with shampoo, rinsed again, and then dried.
The oxidizing composition of the present invention may also comprise various adjuvants conventionally used in compositions for dyeing the hair, and as defined above.
The pH of the oxidizing composition comprising at least one oxidizing agent is such that, after mixing with the dye composition, the pH of the resulting composition that is applied to the keratin fibres ranges, for example, from about 3 to about 12, and further for example, from about 5 to about 11. The pH may be adjusted to the desired value by means of acidifying or basifying agents conventionally used in dyeing human keratin fibres, such as those defined above.
The composition which is finally applied to the fibres may be in various forms, such as liquids, creams, gels, or in any other form which is suitable for dyeing human keratin fibres, such as hair.
Another aspect of the invention is a multicompartment device or dyeing “kit” in which a first compartment comprises the dye composition of the invention and a second compartment comprises the oxidizing composition. This device may be equipped with a means for applying the desired mixture to the hair, such as the devices described in patent FR-2 586 913.
Yet another aspect of the invention is also the novel monocationic monoazo compounds of formula (I) as defined above wherein, in formula (II), n is chosen from 0, 2, and 3.
Another aspect of the invention is also the addition of the monocationic monoazo dyes of formula (I), as direct dyes, in a composition for dyeing human keratin fibres, such as hair, as well as a method of preparation thereof.
The compounds of the invention may be obtained conventionally from a diazonium salt of 2-aminobenzimidazole. The diazonium preparation is known and described in the literature, and it is carried out in a dilute hydrochloric acid medium.
The diazonium salt is then condensed with a compound from the family of the cyclic N,N-dialkyls of anilines, in the presence of an organic base.
At the end of this condensation, the reaction medium is brought back to basic pH and the azo compound thus formed is isolated.
The azo compound thus obtained is quaternized in a solvent at a temperature ranging from 40° C. to 140° C. using an alkylating agent.
Thus, for example, the 2-aminobenzimidazole derivatives react with sodium nitrite in an acid medium to produce the diazonium reactive intermediate, which, itself, is reacted with a cyclic aniline derivative. The preparations are known and fully described in U.S. Pat. Nos. 5,208,325 and 5,436,323. The protocol is also applied to 2-aminobenzoxazole and 2-aminobenzothiazole derivatives.
The corresponding azo compounds are then quaternized with the halides R13—X according to the following reaction scheme:
Figure US06824570-20041130-C00006
The corresponding monocationic monoazo dyes of formula (I) may be obtained by applying the same synthetic process to pyridine derivatives and pyridazine derivatives substituted with a cyclic amine comprising 5 to 8 ring members.
The examples which follow serve to illustrate the invention without, however, being limiting in nature.
EXAMPLE OF SYNTHESIS
The compound in accordance with the invention, with the following formula, was prepared:
Figure US06824570-20041130-C00007
First Stage
Synthesis of (1H-benzoimidazol-2-yl)-(4-pyrrolidin-1-ylphenyl)diazene of formula:
Figure US06824570-20041130-C00008
5.42 g (4×10−2 mol) of 2-aminobenzimidazole were solubilized in 400 ml of orthophosphoric acid in a fully equipped round-bottomed flask.
After cooling to 0° C., a solution of sodium nitride (3.92 g in 20 ml of water) was run in over 30 minutes, and the mixture was then stirred for 15 minutes.
Next, 1.5 kg of ice were added over 30 minutes with stirring.
An ethanolic solution of 1-phenylpyrrolidine (5.4 g in 20 ml of ethanol) was then added dropwise for 30 minutes.
At 0° C., the pH of the medium was brought back to 7 with an aqueous ammonia solution and the brick-red product formed was filtered off over a No. 4 sintered glass funnel and then washed with 10 times 100 ml of water. After drying, 2 grams of brick-red product were recovered.
Second Stage
Figure US06824570-20041130-C00009
1.51 g (5.2×10−3 mol) of (1H-benzoimidazol-2-yl)-(4-pyrrolidin-1-ylphenyl)diazene obtained as described above, 10 ml of anhydrous dichloroethane, 1.4 g (10−3 mol) of sodium acetate and 1.08 ml of dimethyl sulphate were introduced into a fully equipped round-bottomed flask.
The mixture was brought to 50° C. for 1 hour and 30 minutes with stirring. The solid was filtered off, washed with dichloroethane and then dried. 2.08 g of dark violet powder were obtained, having the following UV absorption characteristics:
UV (ethanol) λmax=576 nm
εmax=30 000 L·mol−1 cm−1
1H NMR: (400 MHz-DMSO) ppm: standard
Example of Application
A dye composition comprising 1.25 grams of dye prepared in the previous example, 13 grams of an aqueous ammonia solution comprising 40% of ammonia by weight, and demineralised water q.s. for 100 grams was mixed at the time of use with a 20-volumes aqueous hydrogen peroxide composition, in a proportion of 1 part dye composition for 1.5 parts oxidizing composition. The mixture obtained was applied to locks of natural and permanent-waved hair comprising 90% white hairs (1 gram of hair per 10 grams of mixture).
The composition was left to stand on the locks of hair for 35 minutes at ambient temperature.
The locks were then rinsed with water, shampooed and then dried.
They were dyed in a shade of iridescent deep purple to deep purple very resistant to light.

Claims (56)

What is claimed is:
1. A cosmetic composition for dyeing human keratin fibres comprising, in a cosmetically acceptable medium, at least one monocationic monoazo dye of formula (I) below:
W1—W2—N═N—W3  Formula (I)
wherein:
W1 is chosen from 5-, 6-, 7- and 8-membered heterocycles of formula (II) below:
Figure US06824570-20041130-C00010
W2 is chosen from divalent, aromatic, and carbon-based pyridines and pyridazines of formula (III) below:
Figure US06824570-20041130-C00011
W3 is chosen from cationic heteroaromatic radicals of formula (IV) below:
Figure US06824570-20041130-C00012
wherein in formulae (II), (III) and (IV):
n=0, 1, 2 or 3, provided that when n is greater than or equal to 2, then the R4 radicals may be identical or different,
X1 is chosen from a nitrogen atom and CR7 radicals,
X2 is chosen from a nitrogen atom and CR8 radicals,
Z1 is chosen from CHR2 radicals, oxygen and sulphur atoms, and NR14 radicals,
Z2 is chosen from oxygen and sulphur atoms, and NR15 radicals,
R0, R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11 and R12, which may be identical or different, are each chosen from a hydrogen atom, linear and branched C1-C10 hydrocarbon-based chains, possibly forming at least one carbon-based ring comprising from 3 to 6 members, and being saturated or unsaturated, wherein at least one carbon atom of the hydrocarbon-based chains may be replaced with an entity chosen from oxygen, nitrogen, and sulphur atoms, and an SO2group, and wherein the carbon atoms may be, independently of one another, substituted; R0, R1, R2, R3, R4, R5, R6, R7, R8, R9, R11 and R12 comprising no peroxide bond, nor any diazo or nitroso radicals,
R14 is chosen from a hydrogen atom, linear and branched C1-C10 hydrocarbon-based chains, possibly forming at least one carbon-based ring comprising from 3 to 6 members, and being saturated or unsaturated, wherein at least one carbon atom of the hydrocarbon-based chains may be replaced with an entity chosen from oxygen, nitrogen, and sulphur atoms, and an SO2 group, and wherein the carbon atoms may be, independently of one another, substituted, R14 comprising no peroxide bond, nor any diazo or nitroso radicals; provided that said oxygen, nitrogen and sulphur atoms are not linked directly to the nitrogen atom carrying the R14 radical,
R5 with R6 may optionally form a carbon-based aromatic ring,
R13 and R15, which may be identical or different, are each chosen from C1-C8 alkyl radicals optionally substituted with at least one radical chosen from hydroxyl, C1-C2 alkoxy, C2-C4 (poly)hydroxyalkoxy, unsubstituted and substituted amino, carboxyl, sulphonic, and phenyl radicals, which are optionally substituted;
the bond a of the cationic ring of formula (IV) is linked to the azo group of formula (I);
X is an anion chosen from organic and inorganic anions.
2. The composition according to claim 1, wherein said human keratin fibres are hair, wherein the carbon atoms may be, independently of one another, substituted with at least one halogen atom, both for R0 to R12 and for R14, and further wherein for R13 and R15, said unsubstituted and substituted amino radicals are chosen from unsubstituted amino and C1-C2 (di)alkylamino.
3. The composition according to claim 1, wherein, in formula (I), R1, R2, and R3, which may be identical or different, are each chosen from a hydrogen atom; alkoxy, hydroxyl, substituted and unsubstituted amino, and acetoxy radicals; linear and branched C1-C4 alkyl radicals substituted with at least one substituent chosen from halogen atoms, hydroxyl, C1-C2 alkoxy, (poly)hydroxyalkoxy, unsubstituted amino, C1-C2 (di)alkylamino, carboxyl, and sulphonic radicals; and —NR16R17 groups, wherein R16 and R17, which may be identical or different, are each chosen from a hydrogen atom, methylsulphonyl, carboxyl, carboxamido, and C1-C4 alkyl radicals substituted with at least one substituent chosen from halogen atoms, hydroxyl, C1-C2 alkoxy, unsubstituted amino, C1-C2 (di)alkylamino, and carboxyl radicals.
4. The composition according to claim 3, wherein R1, R2 and R3, which may be identical or different, are each chosen from a hydrogen atom; a hydroxyl radical; amino radicals which are optionally mono- or disubstituted; linear and branched C1-C3 alkyl radicals optionally substituted with at least one radical chosen from hydroxyl, C1-C2 alkoxy, unsubstituted amino, C1-C2 (di)alkylamino, carboxyl and sulphonic radicals.
5. The composition according to claim 4, wherein R1, R2 and R3, which may be identical or different, are each chosen from a hydrogen atom, a methyl radical, a hydroxyl radical, an unsubstituted amino radical, a (di)methylamino radical, a methylsulphonylamino radical, C2-C4 (poly)hydroxyalkylamino radicals, and a hydroxymethyl radical.
6. The composition according to claim 1, wherein R1 in formula (II) is chosen from a hydrogen atom, and methyl, hydroxyl, unsubstituted amino, methylamino, dimethylamino and 2-hydroxyethylamino radicals.
7. The composition according to claim 6, wherein R1 in formula (II) is chosen from a hydrogen atom, and hydroxyl, unsubstituted amino, and dimethylamino radicals.
8. The composition according to claim 7, wherein R1 in formula (II) is chosen from a hydrogen atom, and a hydroxyl radical.
9. The composition according claim 1, wherein R0 in formula (II) is chosen from a hydrogen atom, and linear and branched C1-C4 alkyl radicals substituted with at least one radical chosen from hydroxyl, methoxy, unsubstituted amino, (di)alkylamino, carboxyl, sulphonyl, amido, and dimethylamido radicals.
10. The composition according claim 1, wherein R0 in formula (II) is chosen from a hydrogen atom, and carboxyl, amido, dimethylamido, and hydroxymethyl radicals.
11. The composition according claim 10, wherein R0 in formula (II) is a hydrogen atom.
12. The composition according to claim 1, wherein Z1 in formula (II) is chosen from NR14 radicals and CHR2 radicals.
13. The composition according to claim 12, wherein Z1 in formula (II) is chosen from CHR2 radicals.
14. The composition according to claim 12, wherein Z1 in formula (II) is chosen from CH2, CHOH, CHNH2, and CHN(CH3)2.
15. The composition according to claim 14, wherein Z1 in formula (II) is CH2.
16. The composition according to claim 1, wherein n in formula (II) is chosen from 0 and 1.
17. The composition according to claim 16, wherein n in formula (II) is 0.
18. The composition according to claim 1, wherein R5, R6, R7, R8, R9, R10, R11 and R12, which may be identical or different, are each chosen from a hydrogen atom, and methyl, ethyl, isopropyl, methoxymethyl, hydroxymethyl, 1-carboxymethyl, 1-aminomethyl, 2-carboxyethyl, 2-hydroxyethyl, 3-hydroxypropyl, 1,2-dihydroxyethyl, 1-hydroxy-2-aminoethyl, 2-hydroxy-1-aminoethyl, methoxy, ethoxy, 2-hydroxyethyloxy, 3-aminoethyloxy, unsubstituted amino, methylamino, dimethylamino, and 2-hydroxyethylamino radicals.
19. The composition according to claim 18, wherein R5, R6, R7, R8, R9, R10, R11 and R12, which may be identical or different, are each chosen a hydrogen atom, and methyl, hydroxymethyl, 2-hydroxyethyl, 1,2-dihydroxyethyl, methoxy, 2-hydroxyethyloxy, unsubstituted amino, and 2-hydroxyethylamino radicals.
20. The composition according to claim 19, wherein R5, R6, R7, R8, R9, R10, R11 and R12, which may be identical or different, are each chosen from a hydrogen atom, and methyl, methoxy, and unsubstituted amino radicals.
21. The composition according to claim 1, wherein said carbon-based aromatic ring optionally formed by R5 with R6 is phenyl.
22. The composition according to claim 1, wherein X1 in formula (III) is chosen from CR7 radicals, wherein R7 is chosen from a hydrogen atom, and methyl, ethyl, isopropyl, methoxymethyl, hydroxymethyl, 1-carboxymethyl, 1-aminomethyl, 2-carboxyethyl, 2-hydroxyethyl, 3-hydroxypropyl, 1,2-dihydroxyethyl, 1-hydroxy-2-aminoethyl, 2-hydroxy-1-aminoethyl, methoxy, ethoxy, 2-hydroxyethyloxy, 3-aminoethyloxy, unsubstituted amino, methylamino, dimethylamino, and 2-hydroxyethylamino radicals.
23. The composition according to claim 1, wherein X2 in formula (III) is chosen from CR8 radicals, wherein R8 is chosen from a hydrogen atom, and methyl, ethyl, isopropyl, methoxymethyl, hydroxymethyl, 1-carboxymethyl, 1-aminomethyl, 2-carboxyethyl, 2-hydroxyethyl, 3-hydroxypropyl, 1,2-dihydroxyethyl, 1-hydroxy-2-aminoethyl, 2-hydroxy-1-aminoethyl, methoxy, ethoxy, 2-hydroxyethyloxy, 3-aminoethyloxy, unsubstituted amino, methylamino, dimethylamino, and 2-hydroxyethylamino radicals.
24. The composition according to claim 1, wherein R13 and R15, which may be identical or different, are each chosen from C1-C4 alkyl radicals optionally substituted with at least one radical chosen from hydroxyl, C1-C2 alkoxy, unsubstituted amino, C1-C2 (di)alkylamino, carboxyl, sulphonic, and phenyl radicals.
25. The composition according to claim 24, wherein R13 and R15, which may be identical or different, are each chosen from methyl, ethyl, 2-hydroxyethyl, 1-carboxymethyl, 2-carboxyethyl, and 2-sulphonylethyl radicals.
26. The composition according to claim 24, wherein R13 and R15, which may be identical or different, are each chosen from C1-C3 alkyl radicals optionally substituted with at least one radical chosen from hydroxyl, methoxy, unsubstituted amino, dimethylamino, carboxyl, and sulphonic radicals.
27. The composition according to claim 26, wherein R13 and R15, which may be identical or different, are each chosen from methyl, ethyl, 2-hydroxyethyl, and carboxy-methyl radicals.
28. The composition according to claim 27, wherein R13 and R15 are each a methyl radical.
29. The composition according to claim 12, wherein Z1 is chosen from NR14 radicals, wherein R14 is chosen from a hydrogen atom, and linear and branched C1-C3 alkyl radicals optionally substituted with at least one radical chosen from hydroxyl, methoxy, unsubstituted amino, methylamino, dimethylamino, carboxyl, and sulphonyl radicals.
30. The composition according to claim 29, wherein R14 is chosen from a hydrogen atom, and methyl and 2-hydroxyethyl radicals.
31. The composition according to claim 1, wherein Z2 in formula (IV) is chosen from NR15 radicals, wherein R15 is chosen from C1-C4 alkyl radicals optionally substituted with at least one radical chosen from hydroxyl, C1-C2 alkoxy, unsubstituted amino, C1-C2 (di)alkylamino, carboxyl, sulphonic, and phenyl radicals.
32. A cosmetic composition for dyeing human keratin fibres comprising, in a cosmetically acceptable medium, at least one dye chosen from:
1,3-dimethyl-2-[4-(pyrrolidin-1-yl)phenylazo]benzimidazol-1-ium,
1,3-dimethyl-2-[4-(3-hydroxypyrrolidin-1-yl)phenylazo]benzimidazol-1-ium,
1,3-dimethyl-2-[4-(2-carboxypyrrolidin-1-yl)phenylazo]benzimidazol-1-ium,
1,3-dimethyl-2-[4-(3-aminopyrrolidin-1-yl)phenylazo]benzimidazol-1-ium,
1,3-dimethyl-2-[4-(2-carboxy-3-hydroxypyrrolidin-1-yl)phenylazo]benzimidazol-1-ium,
1,3-dimethyl-2-[4-(2-carboxamidopyrrolidin-1-yl)phenylazo]benzimidazol-1-ium,
1,3-dimethyl-2-[4-(2-hydroxymethylpyrrolidin-1-yl)phenylazo]benzimidazol-1-ium,
1,3-dimethyl-2-[4-(2-carboxy-4-hydroxypyrrolidin-1-yl)phenylazo]benzimidazol-1-ium,
1,3-dimethyl-2-[4-(piperidin-1-yl)phenylazo]benzimidazol-1-ium,
1,3-dimethyl-2-[4-(3-hydroxypiperidin-1-yl)phenylazo]benzimidazol-1-ium,
1,3-dimethyl-2-[4-(3-hydroxymethylpiperidin-1-yl)phenylazo]benzimidazol-1-ium,
1,3-dimethyl-2-[4-(3-carboxypiperidin-1-yl)phenylazo]benzimidazol-1-ium,
1,3-dimethyl-2-[4-(2-carboxypiperidin-1-yl)phenylazo]benzimidazol-1-ium,
1,3-dimethyl-2-[4-(piperazin-1-yl)phenylazo]benzimidazol-1-ium,
1,3-dimethyl-2-[4-(homopiperazin-1-yl)phenylazo]benzimidazol-1-ium,
5-amino-1,3-dimethyl-2-[4-(pyrrolidin-1-yl)phenylazo]benzimidazol-1-ium,
5-amino-1,3-dimethyl-2-[4-(3-hydroxypyrrolidin-1-yl)phenylazo]benzimidazol-1-ium,
5-amino-1,3-dimethyl-2-[4-(2-carboxypyrrolidin-1-yl)phenylazo]benzimidazol-1-ium,
5-amino-1,3-dimethyl-2-[4-(3-aminopyrrolidin-1-yl)phenylazo]benzimidazol-1-ium,
5-amino-1,3-dimethyl-2-[4-(2-carboxy-3-hydroxypyrrolidin-1-yl)phenylazo]benzimidazol-1-ium,
5-amino-1,3-dimethyl-2-[4-(2-carboxamidopyrrolidin-1-yl)phenylazo]benzimidazol-1-ium,
5-amino-1,3-dimethyl-2-[4-(2-hydroxymethylpyrrolidin-1-yl)phenylazo]benzimidazol-1-ium,
5-amino-1,3-dimethyl-2-[4-(2-carboxy-4-hydroxypyrrolidin-1-yl)phenylazo]benzimidazol-1-ium,
5-amino-1,3-dimethyl-2-[4-(piperidin-1-yl)phenylazo]benzimidazol-1-ium,
5-amino-1,3-dimethyl-2-[4-(3-hydroxypiperidin-1-yl)phenylazo]benzimidazol-1-ium,
5-amino-1,3-dimethyl-2-[4-(3-hydroxymethylpiperidin-1-yl)phenylazo]benzimidazol-1-ium,
5-amino-1,3-dimethyl-2-[4-(3-carboxypiperidin-1-yl)phenylazo]benzimidazol-1-ium,
5-amino-1,3-dimethyl-2-[4-(2-carboxypiperidin-1-yl)phenylazo]benzimidazol-1-ium,
5-amino-1,3-dimethyl-2-[4-(piperazin-1-yl)phenylazo]benzimidazol-1-ium,
5-amino-1,3-dimethyl-2-[4-(homopiperazin-1-yl)phenylazo]benzimidazol-1-ium,
5-dimethylamino-1,3-dimethyl-2-[4-(pyrrolidin-1-yl)phenylazo]benzimidazol-1-ium,
5-dimethylamino-1,3-dimethyl-2-[4-(3-hydroxypyrrolidin-1-yl)phenylazo]benzimidazol-1-ium,
5-dimethylamino-1,3-dimethyl-2-[4-(2-carboxypyrrolidin-1-yl)phenylazo]benzimidazol-1-ium,
5-dimethylamino-1,3-dimethyl-2-[4-(3-aminopyrrolidin-1-yl)phenylazo]benzimidazol-1-ium,
5-dimethylamino-1,3-dimethyl-2-[4-(2-carboxy-3-hydroxypyrrolidin-1-yl)phenylazo]benzimidazol-1-ium,
5-dimethylamino-1,3-dimethyl-2-[4-(2-carboxamidopyrrolidin-1-yl)phenylazo]benzimidazol-1-ium,
5-dimethylamino-1,3-dimethyl-2-[4-(2-hydroxymethylpyrrolidin-1-yl)phenylazo]benzimidazol-1-ium,
5-dimethylamino-1,3-dimethyl-2-[4-(2-carboxy-4-hydroxypyrrolidin-1-yl)phenylazo]benzimidazol-1-ium,
5-dimethylamino-1,3-dimethyl-2-[4-(piperidin-1-yl)phenylazo]benzimidazol-1-ium,
5-dimethylamino-1,3-dimethyl-2-[4-(3-hydroxypiperidin-1-yl)phenylazo]benzimidazol-1-ium,
5-dimethylamino-1,3-dimethyl-2-[4-(3-hydroxymethylpiperidin-1-yl)phenylazo]benzimidazol-1-ium,
5-dimethylamino-1,3-dimethyl-2-[4-(3-carboxypiperidin-1-yl)phenylazo]benzimidazol-1-ium,
5-dimethylamino-1,3-dimethyl-2-[4-(2-carboxypiperidin-1-yl)phenylazo]benzimidazol-1-ium,
5-dimethylamino-1,3-dimethyl-2-[4-(piperazin-1-yl)phenylazo]benzimidazol-1-ium, and
5-dimethylamino-1,3-dimethyl-2-[4-(homopiperazin-1-yl)phenylazo]benzimidazol-1-ium.
33. The composition according to claim 1, wherein X is chosen from halides, a hydroxide, a sulphate, a hydrogen sulphate, (C1-C6) alkyl sulphates, an acetate, a tartrate, an oxalate, (C1-C6) alkylsulphonates, and arylsulphonates which may be optionally substituted with at least one radical chosen from C1-C4 alkyl radicals.
34. The composition according to claim 1, wherein said at least one monocationic monoazo dye of formula (I) is present at a concentration ranging from about 0.001% to about 5% by weight relative to the total weight of the dye composition.
35. The composition according to claim 34, wherein said at least one monocationic monoazo dye of formula (I) is present at a concentration ranging from about 0.05% to about 2% by weight relative to the total weight of the dye composition.
36. A composition according to claim 1, further comprising at least one direct dye, which is different from those of formula (I), chosen from neutral, acidic, and cationic nitrobenzene direct dyes, neutral, acidic and cationic azo direct dyes, neutral, acidic and cationic quinone direct dyes, azine direct dyes, methine direct dyes, triarylmethane direct dyes, indoamine direct dyes, and natural direct dyes.
37. The composition according to claim 36, wherein said quinone direct dyes are chosen from anthraquinone direct dyes.
38. A composition according to claim 1, further comprising at least one oxidizing agent.
39. The composition according to claim 38, wherein said at least one oxidizing agent is hydrogen peroxide.
40. The composition according to claim 1, further comprising at least one oxidation base.
41. The composition according to claim 40, wherein said at least one oxidation base is chosen from para-phenylenediamines, bisphenylalkylenediamines, para-aminophenols, ortho-aminophenols, and heterocyclic bases, and the acid addition salts thereof.
42. The composition according to claim 1, further comprising at least one coupler.
43. The composition according to claim 42, wherein said at least one coupler is chosen from meta-phenylenediamines, meta-aminophenols, meta-diphenols, naphthalene couplers, and heterocyclic couplers, and the acid addition salts thereof.
44. A process for the direct dyeing of human keratin fibres, comprising applying to the human keratin fibres a dye composition comprising at least one monocationic monoazo dye of formula (I) below:
W1—W2—N═N—W3  Formula (I)
wherein:
W1 is chosen from 5-, 6-, 7- and 8-membered heterocycles of formula (II) below:
Figure US06824570-20041130-C00013
W2 is chosen from divalent, aromatic, and carbon-based pyridines and pyridazines of formula (III) below:
Figure US06824570-20041130-C00014
W3 is chosen from cationic heteroaromatic radicals of formula (IV) below:
Figure US06824570-20041130-C00015
wherein in formulae (II), (III) and (IV):
n=0, 1, 2 or 3, provided that when n is greater than or equal to 2, then the R4 radicals may be identical or different,
X1 is chosen from a nitrogen atom and CR7 radicals,
X2 is chosen from a nitrogen atom and CR8 radicals,
Z1 is chosen from CHR2 radicals, oxygen and sulphur atoms, and NR14 radicals,
Z2 is chosen from oxygen and sulphur atoms, and NR15 radicals,
R0, R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11 and R12, which may be identical or different, are each chosen from a hydrogen atom, linear and branched C1-C10 hydrocarbon-based chains, possibly forming at least one carbon-based ring comprising from 3 to 6 members, and being saturated or unsaturated, wherein at least one carbon atom of the hydrocarbon-based chains may be replaced with an entity chosen from oxygen, nitrogen, and sulphur atoms, and an SO2 group, and wherein the carbon atoms may be, independently of one another, substituted; R0, R1, R2, R3, R4, R5, R6, R7, R8, R9, R11 and R12 comprising no peroxide bond, nor any diazo or nitroso radicals,
R14 is chosen from a hydrogen atom, linear and branched C1-C10 hydrocarbon-based chains, possibly forming at least one carbon-based ring comprising from 3 to 6 members, and being saturated or unsaturated, wherein at least one carbon atom of the hydrocarbon-based chains may be replaced with an entity chosen from oxygen, nitrogen, and sulphur atoms, and an SO2 group, and wherein the carbon atoms may be, independently of one another, substituted, R14 comprising no peroxide bond, nor any diazo or nitroso radicals; provided that said oxygen, nitrogen and sulphur atoms are not linked directly to the nitrogen atom carrying the R14 radical,
R5 with R6 may optionally form a carbon-based aromatic ring,
R13 and R15, which may be identical or different, are each chosen from C1-C8 alkyl radicals optionally substituted with at least one radical chosen from hydroxyl, C1-C2 alkoxy, C2-C4 (poly)hydroxyalkoxy, unsubstituted and substituted amino, carboxyl, sulphonic, and phenyl radicals, which are optionally substituted;
the bond a of the cationic ring of formula (IV) is linked to the azo group of formula (I);
X is an anion chosen from organic and inorganic anions.
45. The process according to claim 44, wherein said human keratin fibres are hair.
46. The process according to claim 45, wherein said dye composition further comprises at least one oxidizing agent.
47. The process according to claim 46, wherein said at least one oxidizing agent is mixed with said dye composition at the time of use.
48. The process according to claim 46, wherein said at least one oxidizing agent is applied to said human keratin fibres in the form of an oxidizing composition simultaneously with or sequentially to the dye composition.
49. A process for the oxidation dyeing of human keratin fibres comprising applying to the human keratin fibres a dye composition comprising at least one monocationic monoazo dye of formula (I) below:
W1—W2—N═N—W3  Formula (I)
wherein:
W1 is chosen from 5-, 6-, 7- and 8-membered heterocycles of formula (II) below:
Figure US06824570-20041130-C00016
W2 is chosen from divalent, aromatic, and carbon-based pyridines and pyridazines of formula (III) below:
Figure US06824570-20041130-C00017
W3 is chosen from cationic heteroaromatic radicals of formula (IV) below:
Figure US06824570-20041130-C00018
wherein in formulae (II), (III) and (IV):
n=0, 1, 2 or 3, provided that when n is greater than or equal to 2, then the R4 radicals may be identical or different,
X1 is chosen from a nitrogen atom and CR7 radicals,
X2 is chosen from a nitrogen atom and CR8 radicals,
Z1 is chosen from CHR2 radicals, oxygen and sulphur atoms, and NR14 radicals,
Z2 is chosen from oxygen and sulphur atoms, and NR15 radicals,
R0, R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11 and R12, which may be identical or different, are each chosen from a hydrogen atom, linear and branched C1-C10 hydrocarbon-based chains, possibly forming at least one carbon-based ring comprising from 3 to 6 members, and being saturated or unsaturated, wherein at least one carbon atom of the hydrocarbon-based chains may be replaced with an entity chosen from oxygen, nitrogen, and sulphur atoms, and an SO2 group, and wherein the carbon atoms may be, independently of one another, substituted; R0, R1, R2, R3, R4, R5, R6, R7, R8, R9, R11 and R12 comprising no peroxide bond, nor any diazo or nitroso radicals,
R14 is chosen from a hydrogen atom, linear and branched C1-C10 hydrocarbon-based chains, possibly forming at least one carbon-based ring comprising from 3 to 6 members, and being saturated or unsaturated, wherein at least one carbon atom of the hydrocarbon-based chains may be replaced with an entity chosen from oxygen, nitrogen, and sulphur atoms, and an SO2 group, and wherein the carbon atoms may be, independently of one another, substituted, R14 comprising no peroxide bond, nor any diazo or nitroso radicals; provided that said oxygen, nitrogen and sulphur atoms are not linked directly to the nitrogen atom carrying the R14 radical,
R5 with R6 may optionally form a carbon-based aromatic ring,
R13 and R15, which may be identical or different, are each chosen from C1-C8 alkyl radicals optionally substituted with at least one radical chosen from hydroxyl, C1-C2 alkoxy, C2-C4 (poly)hydroxyalkoxy, unsubstituted and substituted amino, carboxyl, sulphonic, and phenyl radicals, which are optionally substituted;
the bond a of the cationic ring of formula (IV) is linked to the azo group of formula (I);
X is an anion chosen from organic and inorganic anions;
at least one oxidation base, and, optionally, at least one coupler, in the presence of at least one oxidizing agent.
50. The process according to claim 49, wherein said human keratin fibres are hair.
51. The process according to claim 49, wherein said at least one oxidizing agent is mixed with the dye composition at the time of use.
52. The process according to claim 49, wherein said at least one oxidizing agent is applied to the fibres in the form of an oxidizing composition simultaneously with or sequentially to the dye composition.
53. A multicompartment device or multicompartment dyeing kit for dyeing human keratin fibres, comprising a first compartment (1) comprising a composition comprising at least one monocationic monoazo dye of formula (I) below:
W1—W2—N═N—W3  Formula (I)
wherein:
W1 is chosen from 5-, 6-, 7- and 8-membered heterocycles of formula (II) below:
Figure US06824570-20041130-C00019
W2 is chosen from divalent, aromatic, and carbon-based pyridines and pyridazines of formula (III) below:
Figure US06824570-20041130-C00020
W3 is chosen from cationic heteroaromatic radicals of formula (IV) below:
Figure US06824570-20041130-C00021
wherein in formulae (II), (III) and (IV):
n=0, 1, 2 or 3, provided that when n is greater than or equal to 2, then the R4 radicals may be identical or different,
X1 is chosen from a nitrogen atom and CR7 radicals,
X2 is chosen from a nitrogen atom and CR8 radicals,
Z1 is chosen from CHR2 radicals, oxygen and sulphur atoms, and NR14 radicals,
Z2 is chosen from oxygen and sulphur atoms, and NR15 radicals,
R0, R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11 and R12, which may be identical or different, are each chosen from a hydrogen atom, linear and branched C1-C10 hydrocarbon-based chains, possibly forming at least one carbon-based ring comprising from 3 to 6 members, and being saturated or unsaturated, wherein at least one carbon atom of the hydrocarbon-based chains may be replaced with an entity chosen from oxygen, nitrogen, and sulphur atoms, and an SO2 group, and wherein the carbon atoms may be, independently of one another, substituted; R0, R1, R2, R3, R4, R5, R6, R7, R8, R9, R11 and R12 comprising no peroxide bond, nor any diazo or nitroso radicals,
R14 is chosen from a hydrogen atom, linear and branched C1-C10 hydrocarbon-based chains, possibly forming at least one carbon-based ring comprising from 3 to 6 members, and being saturated or unsaturated, wherein at least one carbon atom of the hydrocarbon-based chains may be replaced with an entity chosen from oxygen, nitrogen, and sulphur atoms, and an SO2 group, and wherein the carbon atoms may be, independently of one another, substituted, R14 comprising no peroxide bond, nor any diazo or nitroso radicals; provided that said oxygen, nitrogen and sulphur atoms are not linked directly to the nitrogen atom carrying the R14 radical,
R5 with R6 may optionally form a carbon-based aromatic ring,
R13 and R15, which may be identical or different, are each chosen from C1-C8 alkyl radicals optionally substituted with at least one radical chosen from hydroxyl, C1-C2 alkoxy, C2-C4 (poly)hydroxyalkoxy, unsubstituted and substituted amino, carboxyl, sulphonic, and phenyl radicals, which are optionally substituted;
the bond a of the cationic ring of formula (IV) is linked to the azo group of formula (I);
X is an anion chosen from organic and inorganic anions, and
a second compartment (2) comprising an oxidizing composition.
54. At least one monocationic monoazo dye of formula (I) below:
W1—W2—N═N—W3  Formula (I)
wherein:
W1 is chosen from 5-, 6-, 7- and 8-membered heterocycles of formula (II) below:
Figure US06824570-20041130-C00022
W2 is chosen from divalent, aromatic, and carbon-based pyridines and pyridazines of formula (III) below:
Figure US06824570-20041130-C00023
W3 is chosen from cationic heteroaromatic radicals of formula (IV) below:
Figure US06824570-20041130-C00024
wherein in formulae (II), (III) and (IV):
n=0, 2 or 3, provided that when n is greater than or equal to 2, then the R4 radicals may be identical or different,
X1 is chosen from a nitrogen atom and CR7 radicals,
X2 is chosen from a nitrogen atom and CR8 radicals,
Z1 is chosen from CHR2 radicals, oxygen and sulphur atoms, and NR14 radicals,
Z2 is chosen from oxygen and sulphur atoms, and NR15 radicals,
R0, R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11 and R12, which may be identical or different, are each chosen from a hydrogen atom, linear and branched C1-C10 hydrocarbon-based chains, possibly forming at least one carbon-based ring comprising from 3 to 6 members, and being saturated or unsaturated, wherein at least one carbon atom of the hydrocarbon-based chains may be replaced with an entity chosen from oxygen, nitrogen, and sulphur atoms, and an SO2 group, and wherein the carbon atoms may be, independently of one another, substituted; R0, R1, R2, R3, R4, R5, R6, R7, R8, R9, R11 and R12 comprising no peroxide bond, nor any diazo or nitroso radicals,
R14 is chosen from a hydrogen atom, linear and branched C1-C10 hydrocarbon-based chains, possibly forming at least one carbon-based ring comprising from 3 to 6 members, and being saturated or unsaturated, wherein at least one carbon atom of the hydrocarbon-based chains may be replaced with an entity chosen from oxygen, nitrogen, and sulphur atoms, and an SO2 group, and wherein the carbon atoms may be, independently of one another, substituted, R14 comprising no peroxide bond, nor any diazo or nitroso radicals; provided that said oxygen, nitrogen and sulphur atoms are not linked directly to the nitrogen atom carrying the R14 radical,
R5 with R6 may optionally form a carbon-based aromatic ring,
R13 and R15, which may be identical or different, are each chosen from C1-C8 alkyl radicals optionally substituted with at least one radical chosen from hydroxyl, C1-C2 alkoxy, C2-C4 (poly)hydroxyalkoxy, unsubstituted and substituted amino, carboxyl, sulphonic, and phenyl radicals, which are optionally substituted;
the bond a of the cationic ring of formula (IV) is linked to the azo group of formula (I);
X is an anion chosen from organic and inorganic anions.
55. A method of preparing a direct dye composition for dyeing human keratin fibres comprising, including in said direct dye composition, at least one direct dye chosen from monocationic monoazo dyes of formula (I) below:
W1—W2—N═N—W3  Formula (I)
wherein:
W1 is chosen from 5-, 6-, 7- and 8-membered heterocycles of formula (II) below:
Figure US06824570-20041130-C00025
W2 is chosen from divalent, aromatic, an carbon-based pyridines and pyridazines of formula (III) below:
Figure US06824570-20041130-C00026
W3 is chosen from cationic heteroaromatic radicals of formula (IV) below:
Figure US06824570-20041130-C00027
wherein in formulae (II), (III) and (IV):
n=0, 1, 2 or 3, provided that when n is greater than or equal to 2, then the R4 radicals may be identical or different,
X1 is chosen from a nitrogen atom and CR7 radicals,
X2 is chosen from a nitrogen atom and CR8 radicals,
Z1 is chosen from CHR2 radicals, oxygen and sulphur atoms, and NR14 radicals,
Z2 is chosen from oxygen and sulphur atoms, and NR15 radicals,
R0, R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11 and R12, which may be identical or different, are each chosen from a hydrogen atom, linear and branched C1-C10 hydrocarbon-based chains, possibly forming at least one carbon-based ring comprising from 3 to 6 members, and being saturated or unsaturated, wherein at least one carbon atom of the hydrocarbon-based chains may be replaced with an entity chosen from oxygen, nitrogen, and sulphur atoms, and an SO2group, and wherein the carbon atoms may be, independently of one another, substituted; R0, R1, R2, R3, R4, R5, R6, R7, R8, R9, R11 and R12 comprising no peroxide bond, nor any diazo or nitroso radicals,
R14 is chosen from a hydrogen atom, linear and branched C1-C10 hydrocarbon-based chains, possibly forming at least one carbon-based ring comprising from 3 to 6 members, and being saturated or unsaturated, wherein at least one carbon atom of the hydrocarbon-based chains may be replaced with an entity chosen from oxygen, nitrogen, and sulphur atoms, and an SO2 group, and wherein the carbon atoms may be, independently of one another, substituted, R14 comprising no peroxide bond, nor any diazo or nitroso radicals; provided that said oxygen, nitrogen and sulphur atoms are not linked directly to the nitrogen atom carrying the R14 radical,
R5 with R6 may optionally form a carbon-based aromatic ring,
R13 and R15, which may be identical or different, are each chosen from C1-C8 alkyl radicals optionally substituted with at least one radical chosen from hydroxyl, C1-C2 alkoxy, C2-C4 (poly)hydroxyalkoxy, unsubstituted and substituted amino, carboxyl, sulphonic, and phenyl radicals, which are optionally substituted;
the bond a of the cationic ring of formula (IV) is linked to the azo group of formula (I);
X is an anion chosen from organic and inorganic anions.
56. The method according to claim 55, wherein the human keratin fibres are hair.
US10/254,798 2001-09-26 2002-09-26 Composition for dyeing human keratin fibres, comprising a particular monocationic monoazo dye Expired - Fee Related US6824570B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0112374A FR2829926B1 (en) 2001-09-26 2001-09-26 COMPOSITION FOR DYEING KERATINIC FIBERS COMPRISING A SPECIAL DICATION DIAZOIC DYE
FR0112374 2001-09-26

Publications (2)

Publication Number Publication Date
US20030106169A1 US20030106169A1 (en) 2003-06-12
US6824570B2 true US6824570B2 (en) 2004-11-30

Family

ID=8867619

Family Applications (1)

Application Number Title Priority Date Filing Date
US10/254,798 Expired - Fee Related US6824570B2 (en) 2001-09-26 2002-09-26 Composition for dyeing human keratin fibres, comprising a particular monocationic monoazo dye

Country Status (12)

Country Link
US (1) US6824570B2 (en)
EP (1) EP1297819A3 (en)
JP (2) JP2003128525A (en)
KR (1) KR100533486B1 (en)
CN (1) CN1245150C (en)
BR (1) BR0204142A (en)
CA (1) CA2405024A1 (en)
FR (1) FR2829926B1 (en)
HU (1) HUP0203172A2 (en)
MX (1) MXPA02009381A (en)
PL (1) PL356288A1 (en)
RU (1) RU2223744C1 (en)

Cited By (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050235432A1 (en) * 2004-01-28 2005-10-27 Gregory Plos Composition for dyeing keratin fibers, comprising at least one alcohol oxidase, at least one oxidation dye precursor, and at least one azo, methine or azomethine cationic direct dye, and process using this composition
US20060130244A1 (en) * 2004-11-25 2006-06-22 Franck Giroud Aqueous composition for dyeing keratin fibres comprising a dye and a specific block copolymer
US20060149044A1 (en) * 2004-12-15 2006-07-06 Herve David Dissymmetrical diazo compounds comprising 2-pyridinium group and a cationic or non-cationic linker, compositions comprising them, method for coloring, and device
US20060156477A1 (en) * 2004-12-15 2006-07-20 Herve David Symmetrical diazo compounds comprising 2-imidazolium groups and a non-cationic linke, compositions comprising them, method of coloring, and device
US20060156489A1 (en) * 2004-12-15 2006-07-20 Herve David Dyssymmetrical diazo compounds having at least one 4-pyridinium unit and a cationic or non-cationic linker, compositions comprising them, method of coloring, and device
US20060156488A1 (en) * 2004-12-15 2006-07-20 Herve David Symmetrical diazo compounds containing 2-pyridinium groups and a cationic or non-cationic linker, compositions comprising them, method of coloring, and device
US20060156490A1 (en) * 2004-12-15 2006-07-20 Herve David Symmetrical diazo compounds comprising 2-imidazolium groups and a cationic linker, compositions comprising them, method of coloring, and device
US20060156479A1 (en) * 2004-12-23 2006-07-20 Leila Hercouet Use of at least one compound chosen from porphyrin compounds and phthalocyanin compounds for dyeing human keratin materials, compositions comprising them, a dyeing process, and compounds therefor
US20060174422A1 (en) * 2004-12-15 2006-08-10 Herve David Symmetrical diazo compounds comprising 4-pyridinium groups and a cationic or non-cationic linker, compositions comprising them, method for coloring, and device
US20060230546A1 (en) * 2005-02-28 2006-10-19 Eric Bone Anhydrous composition in the form of a film comprising at least one film-forming polymer and at least one oxidation dye, preparation, and dyeing process
US20060242771A1 (en) * 2005-02-28 2006-11-02 Eric Bone Anhydrous composition in the form of a film comprising a film-forming polymer and a direct dye, preparation and dyeing process using the composition
US20060265817A1 (en) * 2005-03-31 2006-11-30 Frederic Legrand Dye composition comprising at least one non-ionic associative polymer and process for dyeing keratin fibers using same
US20070010663A1 (en) * 2004-12-15 2007-01-11 Herve David Dissymmetrical diazo compounds containing having at least one 2-imidazolium unit and a cationic or non-cationic linker, compositions comprising them, method of coloring, and device
US20070044252A1 (en) * 2005-08-25 2007-03-01 Sylvain Kravtchenko Oxidizing composition comprising insoluble compounds, and processes using this composition
US20070044251A1 (en) * 2005-08-25 2007-03-01 Sylvain Kravtchenko Direct dye composition comprising at least one insoluble oxygenated compound, and processes using this composition
US20070044253A1 (en) * 2005-08-25 2007-03-01 Sylvain Kravtchenko Dye composition comprising at least one insoluble compound and processes using this composition
US20070234487A1 (en) * 2006-03-28 2007-10-11 Alain Lagrange Dye composition comprising at least one cationic hydrazone direct dye, dyeing process, and multi-compartment devices
US20080052840A1 (en) * 2006-05-22 2008-03-06 Maxime De Boni Use of an anionic hydrotrope for the colouring of keratinous fibres, composition comprising it and colouring processes employing it
US20080086824A1 (en) * 2006-05-22 2008-04-17 Maxime De Boni Use of a cationic hydrotrope for the direct dyeing of keratinous fibres, composition comprising it and colouring processes employing it
US20080120792A1 (en) * 2005-02-28 2008-05-29 Gregory Plos Dyeing of in Particular Human Keratin Materials by Dry Thermal Transfer of a Direct Azomethine Dye, Composition Comprising the Said Dye and its Method of Preparation
US20080168608A1 (en) * 2005-02-28 2008-07-17 Gregory Plos Dyeing of in Particular Human Keratin Materials by Dry Thermal Transfer of a Direct Anthraquinone Dye, Composition Comprising the Said Dye and Its Method of Preparation
US20080168607A1 (en) * 2004-12-15 2008-07-17 Herve David Unsymmetrical Diazo Compounds, Compositions Comprising Same, Dyeing Method and Device Comprising Said Compositions
US20090044348A1 (en) * 2007-06-22 2009-02-19 Aziz Fadli Coloring composition comprising at least one azomethine compound with a pyrazolinone unit
US7497878B2 (en) 2005-06-30 2009-03-03 L'oreal, S.A. Azo dyes containing a sulphonamide or amide function for the dyeing of human keratin fibers and method of dyeing and dyeing compositions containing them
US7550015B2 (en) 2005-03-31 2009-06-23 L'oreal S.A. Dye composition with a reduced content of starting materials, and process for dyeing keratin fibers using the same
US7569078B2 (en) 2005-03-31 2009-08-04 L'oreal S.A. Dye composition comprising at least one cellulose and process for dyeing keratin fibers using the dye composition
US7575605B2 (en) 2005-03-31 2009-08-18 L'oreal S.A. Dye composition comprising at least one glycerol ester and a process for dyeing keratin fibers using the composition
US7578854B2 (en) 2005-03-31 2009-08-25 L'oreal S.A. Dye composition comprising at least one fatty acid ester and process for dyeing keratin fibers using the same
US7651533B2 (en) 2005-03-31 2010-01-26 Oreal Dye composition with a reduced content of starting materials, process for dyeing keratin fibers using the same and device therefor
US7722680B2 (en) 2005-02-28 2010-05-25 L'oreal S.A. Dyeing of human keratin materials by dry thermal transfer of a direct dye, composition comprising the said dye and its method of preparation

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050119251A1 (en) * 2001-12-21 2005-06-02 Jian-Min Fu Nicotinamide derivatives and their use as therapeutic agents
US7101406B2 (en) * 2002-12-13 2006-09-05 L'oreal Dyeing composition comprising a cationic tertiary para-phenylenediamine and a heterocyclic cationic direct dye, methods and uses
FR2854570B1 (en) * 2003-05-09 2009-07-03 Oreal PROCESS FOR TREATING KERATIN FIBERS USING HEAT
WO2005028467A1 (en) * 2003-09-15 2005-03-31 Anadys Pharmaceuticals, Inc. Antibacterial 3,5-diaminopiperidine-substitute aromatic and heteroaromatic compounds
DE102004008606A1 (en) * 2004-02-21 2005-09-08 Wella Ag Brightening stain with indolylthiazolium azo dyes
AU2005286653A1 (en) * 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Pyridine derivatives for inhibiting human stearoyl-CoA-desaturase
WO2006034279A1 (en) * 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as therapeutic agents
EP2269610A3 (en) * 2004-09-20 2011-03-09 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
WO2006034338A1 (en) * 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as mediators of stearoyl-coa desaturase
WO2006034440A2 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
EP1814551A2 (en) * 2004-09-20 2007-08-08 Xenon Pharmaceuticals Inc. Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase
AU2005286793A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-CoA desaturase enzymes
JP5080256B2 (en) * 2004-09-20 2012-11-21 ゼノン・ファーマシューティカルズ・インコーポレイテッド Bicyclic heterocyclic derivatives and their use as inhibitors of stearoyl-CoA desaturase (SCD)
CA2580856A1 (en) * 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
FR2878154B1 (en) 2004-11-25 2007-02-09 Oreal AQUEOUS COLORING COMPOSITION OF KERATINOUS FIBERS COMPRISING A PARTICULATE BLOCK COLOR AND COPOLYMER
FR2879190B1 (en) 2004-12-15 2007-03-02 Oreal DISSYMETRIC DIAZOIC COMPOUNDS HAVING AT LEAST ONE 4-PYRIDINIUM PATTERN AND CATIONIC OR NON-CATIONIC BINDING ARRANGEMENTS, COMPOSITIONS COMPRISING THEM, COLORING PROCESS AND DEVICE
FR2879193B1 (en) 2004-12-15 2007-08-03 Oreal DISSYMETRIC DIAZOIC COMPOUNDS HAVING AT LEAST ONE 2-IMIDAZOLIUM PATTERN AND CATIONIC OR NON-CATIONIC BINDING ARRANGEMENTS, COMPOSITIONS COMPRISING THE SAME, COLORING PROCESS AND DEVICE
FR2879192B1 (en) 2004-12-15 2007-02-02 Oreal DISSYMETRIC DIAZOIC COMPOUNDS WITH 2-PYRIDINIUM GROUP AND CATIONIC OR NON-CATIONIC BINDING ARRANGEMENTS, COMPOSITIONS COMPRISING THEM, COLORING PROCESS AND DEVICE
FR2879200B1 (en) 2004-12-15 2007-02-02 Oreal 4-PYRIDIUM SYMMETRIC DIAZOIC COMPOUNDS AND CATIONIC OR NON-CATIONIC BINDING ARRANGEMENTS, COMPOSITIONS COMPRISING SAME, COLORING PROCESS AND DEVICE
FR2879195B1 (en) 2004-12-15 2007-03-02 Oreal SYMETRIC DIAZOIC COMPOUNDS WITH 2-PYRIDINIUM GROUTS AND CATIONIC OR NON-CATIONIC BINDING ARMS, COMPOSITIONS COMPRISING THEM, COLORING PROCESS AND DEVICE
FR2882559B1 (en) 2005-02-28 2008-03-21 Oreal ANHYDROUS FILM COMPOSITION COMPRISING A FILMOGENEOUS POLYMER AND AN OXIDIZING AGENT, PREPARATION AND PROCESS FOR TREATING KERATINOUS FIBERS USING THE SAME
FR2882561B1 (en) 2005-02-28 2007-09-07 Oreal ANHYDROUS FILM-FORMING COMPOSITION COMPRISING A FILM-FORMING POLYMER AND A DIRECT COLOR, PREPARATION AND COLORING PROCESS USING THE SAME
FR2882560B1 (en) 2005-02-28 2007-05-18 Oreal FILM-FORMING ANHYDROUS COMPOSITION COMPRISING A FILMOGENEOUS POLYMER AND OXIDATION COLOR, PREPARATION AND COLORING PROCESS USING THE SAME
FR2883737B1 (en) 2005-03-31 2009-06-12 Oreal COLORING COMPOSITION COMPRISING A GLYCERYLE ESTER AND A METHOD OF COLORING KERATIN FIBERS USING THE SAME
FR2883735B1 (en) 2005-03-31 2009-06-12 Oreal COLORING COMPOSITION WITH A REDUCED CONTENT OF RAW MATERIALS, METHOD FOR COLORING KERATINIC FIBERS USING THE SAME AND DEVICE
FR2883736B1 (en) 2005-03-31 2007-05-25 Oreal COLORING COMPOSITION COMPRISING A FATTY ACID ESTER AND METHOD FOR COLORING KERATIN FIBERS USING THE SAME
FR2883734B1 (en) 2005-03-31 2007-09-07 Oreal COLORING COMPOSITION WITH A REDUCED CONTENT OF RAW MATERIALS AND METHOD FOR COLORING KERATIN FIBERS USING THE SAME
FR2883746B1 (en) 2005-03-31 2007-05-25 Oreal COLORING COMPOSITION COMPRISING A CELLULOSE AND METHOD FOR COLORING KERATIN FIBERS USING THE SAME
FR2883738B1 (en) 2005-03-31 2007-05-18 Oreal COLORING COMPOSITION COMPRISING A NONIONIC ASSOCIATIVE POLYMER, METHOD FOR COLORING KERATIN FIBERS USING THE SAME
FR2885045B1 (en) 2005-04-29 2007-06-08 Oreal REVERSE EMULSION COMPRISING A HYDROGEN PEROXIDE SOLUTION AND AN INERT PHASE OF SOLUBILITY IN WATER LESS THAN 1%
CN101208089A (en) * 2005-06-03 2008-06-25 泽农医药公司 Aminothiazole derivatives as human stearoyl-CoA desaturase inhibitors
FR2889944B1 (en) 2005-08-25 2007-11-23 Oreal TINCTORIAL COMPOSITION COMPRISING INSOLUBLE COMPOUNDS, METHODS USING THE SAME.
KR100851614B1 (en) * 2007-02-28 2008-08-12 로레알 Cationic azo dyes with julolidine units, dyeing composition containing them, method of dyeing
FR2929110B1 (en) 2008-03-28 2010-04-16 Oreal AQUEOUS OXIDIZING DISPERSION FOR THE TREATMENT OF KERATINIC FIBERS COMPRISING A NON-IONIC AMPHIPHILIC COMPOUND WITH A HYDROPHOBIC CHARACTER
DE102008046433A1 (en) * 2008-09-09 2010-03-11 Henkel Ag & Co. Kgaa Brightening agent with 2-acylpyridinium derivatives
FR2940090B1 (en) 2008-12-19 2011-02-25 Oreal OXIDIZING COMPOSITION FOR THE TREATMENT OF KERATIN FIBERS COMPRISING OIL, FATTY ALCOHOL AND OXYALKYLENE FATTY ALCOHOL
FR2940067B1 (en) 2008-12-19 2011-02-25 Oreal OXIDIZING COMPOSITION FOR THE TREATMENT OF KERATIN FIBERS COMPRISING A CATIONIC POLYMER, A FATTY AMIDE AND AN OXYGEN AGENT
FR2945041B1 (en) 2009-04-30 2011-04-08 Oreal AZOMETHINIC TYPE COMPONENTS WITH CATIONIC PYRAZOLOPYRIDINE PATTERN FOR COLORING KERATIN FIBERS
FR2944959B1 (en) 2009-04-30 2011-04-08 Oreal USE FOR COLORING KERATIN FIBERS OF A PYRAZOLOPYRIDINE-BASED AZOMETHINIC TYPE COMPOUND
FR3030522B1 (en) 2014-12-19 2017-02-10 Oreal USE FOR THE COLORING OF KERATIN FIBERS OF A TWO PATTERNED AZOMETHINIC TYPE COMPOSITION PYRAZOLOPYRIDINES
FR3030246B1 (en) 2014-12-19 2017-02-10 Oreal USE FOR COLORING KERATIN FIBERS OF AN AZOMETHINIC TYPE COMPOUND WITH A PYRAZOLOPYRIDINE PATTERN
EP3389622B1 (en) 2015-12-18 2023-01-04 L'Oréal Oxidizing composition for treating keratin materials, comprising a fatty substance and oxyalkylenated surfactants
FR3045346B1 (en) 2015-12-21 2019-08-30 L'oreal COLORING COMPOSITION COMPRISING A DIRECT COLOR OF TRIARYLMETHANE STRUCTURE AND SILICONE
FR3045331B1 (en) 2015-12-21 2019-09-06 L'oreal PHACIDIC COLORING COMPOSITION COMPRISING A DIRECT COLOR OF TRIARYLMETHANE STRUCTURE
FR3052969B1 (en) 2016-06-23 2020-02-21 L'oreal USE FOR THE COLORING OF KERATINIC FIBERS OF AN AZOMETHINIC COMPOUND WITH A QUINOLINE-DERIVED PATTERN
FR3053041A1 (en) 2016-06-23 2017-12-29 Oreal AZOMETHINIC (DIS) SYMMETRIC TYPE DIRECT DYE COMPRISING AT LEAST ONE PYRAZOLOPYRIDINE PATTERN, PROCESS FOR COLORING KERATINIC FIBERS FROM THAT COLOR
FR3052970B1 (en) 2016-06-23 2018-06-29 L'oreal PROCESS FOR TREATING KERATIN FIBERS USING AN ANHYDROUS COMPOSITION COMPRISING A TWO-MOLECULAR PYRAZOLOPYRIDINE AZOMETHINIC COMPOUND AND AQUEOUS COMPOSITION
US10034823B2 (en) 2016-09-16 2018-07-31 Noxell Corporation Method of coloring hair with washfast blue imidazolium direct dye compounds
WO2018053034A1 (en) * 2016-09-13 2018-03-22 Noxell Corporation Hair color compositions comprising stable violet-blue to blue imidazolium dyes
FR3060993B1 (en) * 2016-12-22 2020-10-02 Oreal PROCESS FOR COLORING KERATINIC FIBERS USING AT LEAST ONE PARTICULAR 2-AZO (BENZ) IMIDAZOLIUM COMPOUND AND AT LEAST ONE DIRECT FLUORESCENT COLORANT
FR3082119B1 (en) 2018-06-06 2020-05-15 L'oreal COLORING AND / OR LIGHTENING PROCESS FOR KERATINIC MATERIALS
FR3090345B1 (en) * 2018-12-21 2021-06-25 Oreal Process for dyeing keratin materials using a direct dye and an aliphatic ammonium salt and composition comprising them

Citations (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1026978A (en) 1962-03-30 1966-04-20 Schwarzkopf Verwaltung G M B H Method of dyeing hair
GB1153196A (en) 1965-07-07 1969-05-29 Schwarzkopf Verwaltung G M B H Method of Dyeing Hair
FR1584965A (en) 1966-02-15 1970-01-09
US3585182A (en) 1968-02-28 1971-06-15 Eastman Kodak Co Quaternized triazoliumazo - 4 - phenyl-thiomorpholino-1,1-dioxide dyestuffs
GB1276686A (en) 1968-09-18 1972-06-07 Toms River Chemical Corp New process for the alkylation of benzthiazole azo compounds
US3741982A (en) * 1969-09-03 1973-06-26 Mitsubishi Chem Ind Novel basic, cationic dyestuff
GB1360562A (en) 1971-06-04 1974-07-17 Oreal Compositions for dyeing keratinic fibres and diazza-merocyanines for use therein
DE2359399A1 (en) 1973-11-29 1975-06-12 Henkel & Cie Gmbh Tetraaminopyrimidines as developers in oxidation hair dyes - esp. used with meta aminophenol couplers for blue shading dyes
US4003699A (en) 1974-11-22 1977-01-18 Henkel & Cie G.M.B.H. Oxidation hair dyes based upon tetraaminopyrimidine developers
JPS5522638A (en) 1978-08-03 1980-02-18 Haruo Yamaguchi Hairdye
FR2586913A1 (en) 1985-09-10 1987-03-13 Oreal PROCESS FOR FORMING IN IN SITU A COMPOSITION CONSISTING OF TWO PARTS CONDITIONED SEPARATELY AND DISPENSING ASSEMBLY FOR IMPLEMENTING SAID METHOD
JPH0219576A (en) 1988-07-07 1990-01-23 Kao Corp Dyeing composition for keratinous fiber
DE3843892A1 (en) 1988-12-24 1990-06-28 Wella Ag OXIDATION HAIR AGENTS CONTAINING DIAMINOPYRAZOL DERIVATIVES AND NEW DIAMINOPYRAZOLE DERIVATIVES
DE4133957A1 (en) 1991-10-14 1993-04-15 Wella Ag HAIR DYE CONTAINING AMINOPYRAZOLE DERIVATIVES AND NEW PYRAZOLE DERIVATIVES
US5208325A (en) 1991-01-12 1993-05-04 Bayer Aktiengesellschaft Cationic 1,3,4-thiadiazole dyestuffs
JPH05163124A (en) 1991-12-17 1993-06-29 Kao Corp Keratin fiber dyeing composition
WO1994008969A1 (en) 1992-10-16 1994-04-28 Wella Aktiengesellschaft Process for producing 4,5-diamino pyrazole derivatives, their use for colouring hair and novel pyrazole derivatives
WO1994008970A1 (en) 1992-10-16 1994-04-28 Wella Aktiengesellschaft Oxidation hair dye containing 4,5-diaminopyrazole derivatives and novel 4,5-diaminopyrazole derivatives and process for their production
WO1995001772A1 (en) 1993-07-05 1995-01-19 Ciba-Geigy Ag Process for dyeing keratin-containing fibres
WO1995015144A1 (en) 1993-11-30 1995-06-08 Ciba-Geigy Ag Cationic dyes for keratin-containing fibres
US5436323A (en) 1992-07-07 1995-07-25 Bayer Aktiengesellschaft Cationic 1,3,4-thiadiazole dyestuffs
EP0714954A2 (en) 1994-11-03 1996-06-05 Ciba-Geigy Ag Cationic iminazoleazodyestuffs
WO1996016765A1 (en) 1994-11-28 1996-06-06 Philips Electronics N.V. Electrode for electrochemical machining
FR2733749A1 (en) 1995-05-05 1996-11-08 Oreal COMPOSITIONS FOR DYEING KERATINIC FIBERS CONTAINING DIAMINO PYRAZOLES, DYEING PROCESS, NOVEL DIAMINO PYRAZOLES, AND PREPARATION METHOD THEREOF
EP0770375A1 (en) 1995-10-21 1997-05-02 GOLDWELL GmbH Hair dyeing composition
DE19543988A1 (en) 1995-11-25 1997-05-28 Wella Ag Oxidative hair dye composition
FR2741798A1 (en) 1995-12-01 1997-06-06 Oreal LIGHTENING DYE COMPOSITION FOR KERATINIC FIBERS COMPRISING A SPECIFIC DIRECT COLOR
EP0846948A1 (en) 1996-12-09 1998-06-10 Bayer Corporation Mediators useful in an electrochemical biosensor
US6001135A (en) 1996-12-23 1999-12-14 L'oreal Compositions and processes for dyeing keratin fibers with cationic direct dyes, oxidation bases, and oxidizing agents

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3985499A (en) * 1971-06-04 1976-10-12 L'oreal Diazamerocyanines for dyeing keratinous fibers
JPS601135B2 (en) * 1980-12-11 1985-01-12 シャープ株式会社 automatic positioning device
JP2704438B2 (en) * 1989-09-04 1998-01-26 東京エレクトロン株式会社 Ion implanter
DE69821324T2 (en) * 1997-12-05 2004-11-18 L'oreal Two-step process for the direct dyeing of keratin fibers using basic direct dyes
FR2776923B1 (en) * 1998-04-06 2003-01-10 Oreal DYE COMPOSITION FOR KERATINIC FIBERS WITH CATIONIC DIRECT DYE AND SUBSTANTIVE POLYMER
GB9816780D0 (en) * 1998-07-31 1998-09-30 Basf Ag Reactive dyes containing a linkage
FR2822698B1 (en) * 2001-04-03 2006-04-21 Oreal NEW DYE COMPOSITION FOR DYEING KERATIN FIBERS COMPRISING A DICATIONIC MONOAZO DYE

Patent Citations (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1026978A (en) 1962-03-30 1966-04-20 Schwarzkopf Verwaltung G M B H Method of dyeing hair
GB1153196A (en) 1965-07-07 1969-05-29 Schwarzkopf Verwaltung G M B H Method of Dyeing Hair
FR1584965A (en) 1966-02-15 1970-01-09
US3585182A (en) 1968-02-28 1971-06-15 Eastman Kodak Co Quaternized triazoliumazo - 4 - phenyl-thiomorpholino-1,1-dioxide dyestuffs
GB1276686A (en) 1968-09-18 1972-06-07 Toms River Chemical Corp New process for the alkylation of benzthiazole azo compounds
US3741982A (en) * 1969-09-03 1973-06-26 Mitsubishi Chem Ind Novel basic, cationic dyestuff
GB1360562A (en) 1971-06-04 1974-07-17 Oreal Compositions for dyeing keratinic fibres and diazza-merocyanines for use therein
DE2359399A1 (en) 1973-11-29 1975-06-12 Henkel & Cie Gmbh Tetraaminopyrimidines as developers in oxidation hair dyes - esp. used with meta aminophenol couplers for blue shading dyes
US4003699A (en) 1974-11-22 1977-01-18 Henkel & Cie G.M.B.H. Oxidation hair dyes based upon tetraaminopyrimidine developers
JPS5522638A (en) 1978-08-03 1980-02-18 Haruo Yamaguchi Hairdye
FR2586913A1 (en) 1985-09-10 1987-03-13 Oreal PROCESS FOR FORMING IN IN SITU A COMPOSITION CONSISTING OF TWO PARTS CONDITIONED SEPARATELY AND DISPENSING ASSEMBLY FOR IMPLEMENTING SAID METHOD
US4823985A (en) 1985-09-10 1989-04-25 L'oreal Forming in situ a composition consisting of two separately packaged constituents and dispensing assembly for carrying out this process
JPH0219576A (en) 1988-07-07 1990-01-23 Kao Corp Dyeing composition for keratinous fiber
DE3843892A1 (en) 1988-12-24 1990-06-28 Wella Ag OXIDATION HAIR AGENTS CONTAINING DIAMINOPYRAZOL DERIVATIVES AND NEW DIAMINOPYRAZOLE DERIVATIVES
US5061289A (en) 1988-12-24 1991-10-29 Wella Aktiengesellschaft Oxidation hair dye composition containinng diaminopyrazol derivatives and new diaminopyrazol derivatives
US5208325A (en) 1991-01-12 1993-05-04 Bayer Aktiengesellschaft Cationic 1,3,4-thiadiazole dyestuffs
DE4133957A1 (en) 1991-10-14 1993-04-15 Wella Ag HAIR DYE CONTAINING AMINOPYRAZOLE DERIVATIVES AND NEW PYRAZOLE DERIVATIVES
US5380340A (en) 1991-10-14 1995-01-10 Wella Aktiengesellschaft Hair dye containing aminopyrazole derivatives as well as pyrazole derivatives
JPH05163124A (en) 1991-12-17 1993-06-29 Kao Corp Keratin fiber dyeing composition
US5436323A (en) 1992-07-07 1995-07-25 Bayer Aktiengesellschaft Cationic 1,3,4-thiadiazole dyestuffs
WO1994008969A1 (en) 1992-10-16 1994-04-28 Wella Aktiengesellschaft Process for producing 4,5-diamino pyrazole derivatives, their use for colouring hair and novel pyrazole derivatives
WO1994008970A1 (en) 1992-10-16 1994-04-28 Wella Aktiengesellschaft Oxidation hair dye containing 4,5-diaminopyrazole derivatives and novel 4,5-diaminopyrazole derivatives and process for their production
WO1995001772A1 (en) 1993-07-05 1995-01-19 Ciba-Geigy Ag Process for dyeing keratin-containing fibres
WO1995015144A1 (en) 1993-11-30 1995-06-08 Ciba-Geigy Ag Cationic dyes for keratin-containing fibres
US5708151A (en) 1994-11-03 1998-01-13 Ciba Specialty Chemicals Corporation Cationic imidazole azo dyes
EP0714954A2 (en) 1994-11-03 1996-06-05 Ciba-Geigy Ag Cationic iminazoleazodyestuffs
WO1996016765A1 (en) 1994-11-28 1996-06-06 Philips Electronics N.V. Electrode for electrochemical machining
FR2733749A1 (en) 1995-05-05 1996-11-08 Oreal COMPOSITIONS FOR DYEING KERATINIC FIBERS CONTAINING DIAMINO PYRAZOLES, DYEING PROCESS, NOVEL DIAMINO PYRAZOLES, AND PREPARATION METHOD THEREOF
US6099592A (en) 1995-05-05 2000-08-08 L'oreal Composition for dyeing keratin fibers which contain at least one diaminopyrazole, dyeing process, novel diaminopyrazoles and process for their preparation
EP0770375A1 (en) 1995-10-21 1997-05-02 GOLDWELL GmbH Hair dyeing composition
DE19543988A1 (en) 1995-11-25 1997-05-28 Wella Ag Oxidative hair dye composition
US5766576A (en) 1995-11-25 1998-06-16 Wella Aktiengesellschaft Oxidation hair dye compositions containing 3,4,5-triaminopyrazole derivatives and 3,4,5-triaminopyrazole derivatives
FR2741798A1 (en) 1995-12-01 1997-06-06 Oreal LIGHTENING DYE COMPOSITION FOR KERATINIC FIBERS COMPRISING A SPECIFIC DIRECT COLOR
US6368360B2 (en) 1995-12-01 2002-04-09 L'oreal S.A. Method for dyeing keratin fibres with a dye composition containing at least one direct dye and a least one basifying agent
EP0846948A1 (en) 1996-12-09 1998-06-10 Bayer Corporation Mediators useful in an electrochemical biosensor
US6001135A (en) 1996-12-23 1999-12-14 L'oreal Compositions and processes for dyeing keratin fibers with cationic direct dyes, oxidation bases, and oxidizing agents

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
Database CA, Chemical Abstracts Service, Columbus, Ohio, US; Chernov'yants, M. S. et al: "Quaternary 2-azobenzimidazolium salts as indicators with overlapping protonation regions," Database Accession No. 127:67344 XP002199537, 1997.
Database CA, Chemical Abstracts Service, Columbus, Ohio, US; Evlashenkova, I.V. et al: "Acidity function H+ of sulfuric acid solutions," Database Accession No. 126:217134 XP002199538, 1996.
Database CA, Chemical Abstracts Service, Columbus, Ohio, US; Sogomonova, R.A. et al: "Amination of areneazobenzimidazolium salts," Database Accession No. 94:103240 XP002199550, 1980.
English language Derwent Abstract of EP 0 770 375, May 2, 1977.
English language Derwent Abstract of FR 1 584 965, Jan. 9, 1970.
English language Derwent Abstract of JP 2-19576, Jan. 23, 1990.
English language Derwent Abstract of JP 5-153124, Jun. 29, 1993.
English language Derwent Abstract of JP 55-22638, Feb. 18, 1980.

Cited By (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050235432A1 (en) * 2004-01-28 2005-10-27 Gregory Plos Composition for dyeing keratin fibers, comprising at least one alcohol oxidase, at least one oxidation dye precursor, and at least one azo, methine or azomethine cationic direct dye, and process using this composition
US20060130244A1 (en) * 2004-11-25 2006-06-22 Franck Giroud Aqueous composition for dyeing keratin fibres comprising a dye and a specific block copolymer
US20070010663A1 (en) * 2004-12-15 2007-01-11 Herve David Dissymmetrical diazo compounds containing having at least one 2-imidazolium unit and a cationic or non-cationic linker, compositions comprising them, method of coloring, and device
US7288639B2 (en) 2004-12-15 2007-10-30 L'oreal S.A. Dyssymmetrical diazo compounds having at least one 4-pyridinium unit and a cationic or non-cationic linker, compositions comprising them, method of coloring, and device
US20080168607A1 (en) * 2004-12-15 2008-07-17 Herve David Unsymmetrical Diazo Compounds, Compositions Comprising Same, Dyeing Method and Device Comprising Said Compositions
US20060156488A1 (en) * 2004-12-15 2006-07-20 Herve David Symmetrical diazo compounds containing 2-pyridinium groups and a cationic or non-cationic linker, compositions comprising them, method of coloring, and device
US20060156490A1 (en) * 2004-12-15 2006-07-20 Herve David Symmetrical diazo compounds comprising 2-imidazolium groups and a cationic linker, compositions comprising them, method of coloring, and device
US7396368B2 (en) 2004-12-15 2008-07-08 L'oreal S.A. Symmetrical diazo compounds comprising 4-pyridinium groups and a cationic or non-cationic linker, compositions comprising them, method for coloring, and device
US20060174422A1 (en) * 2004-12-15 2006-08-10 Herve David Symmetrical diazo compounds comprising 4-pyridinium groups and a cationic or non-cationic linker, compositions comprising them, method for coloring, and device
US7351267B2 (en) 2004-12-15 2008-04-01 L'oreal S.A. Symmetrical diazo compounds comprising 2-imidazolium groups and a non-cationic linke, compositions comprising them, method of coloring, and device
US7438728B2 (en) 2004-12-15 2008-10-21 L'oreal S.A. Dissymmetrical diazo compounds comprising 2-pyridinium group and a cationic or non-cationic linker, compositions comprising them, method for coloring, and device
US20060156477A1 (en) * 2004-12-15 2006-07-20 Herve David Symmetrical diazo compounds comprising 2-imidazolium groups and a non-cationic linke, compositions comprising them, method of coloring, and device
US20060156489A1 (en) * 2004-12-15 2006-07-20 Herve David Dyssymmetrical diazo compounds having at least one 4-pyridinium unit and a cationic or non-cationic linker, compositions comprising them, method of coloring, and device
US20090062517A2 (en) * 2004-12-15 2009-03-05 L'oreal S.A. Dissymmetrical Diazo Compounds Containing Having at Least One 2-imidazolium Unit and a Cationic or Non-cationic Linker, Compositions Comprising Them, Method of Coloring, and Device
US20060149044A1 (en) * 2004-12-15 2006-07-06 Herve David Dissymmetrical diazo compounds comprising 2-pyridinium group and a cationic or non-cationic linker, compositions comprising them, method for coloring, and device
US7247713B2 (en) 2004-12-15 2007-07-24 L'oreal, S.A. Symmetrical diazo compounds containing 2-pyridinium groups and cationic or non-cationic linker, compositions comprising them, method of coloring, and device
US7429275B2 (en) 2004-12-23 2008-09-30 L'oreal S.A. Use of at least one compound chosen from porphyrin compounds and phthalocyanin compounds for dyeing human keratin materials, compositions comprising them, a dyeing process, and compounds therefor
US20060156479A1 (en) * 2004-12-23 2006-07-20 Leila Hercouet Use of at least one compound chosen from porphyrin compounds and phthalocyanin compounds for dyeing human keratin materials, compositions comprising them, a dyeing process, and compounds therefor
US7645304B2 (en) 2005-02-28 2010-01-12 L'oreal S.A. Dyeing of in particular human keratin materials by dry thermal transfer of a direct azomethine dye, composition comprising the said dye and its method of preparation
US20080168608A1 (en) * 2005-02-28 2008-07-17 Gregory Plos Dyeing of in Particular Human Keratin Materials by Dry Thermal Transfer of a Direct Anthraquinone Dye, Composition Comprising the Said Dye and Its Method of Preparation
US7651535B2 (en) 2005-02-28 2010-01-26 L'oreal S.A. Dyeing of in particular human keratin materials by dry thermal transfer of a direct anthraquinone dye, composition comprising the said dye and its method of preparation
US20060242771A1 (en) * 2005-02-28 2006-11-02 Eric Bone Anhydrous composition in the form of a film comprising a film-forming polymer and a direct dye, preparation and dyeing process using the composition
US20060230546A1 (en) * 2005-02-28 2006-10-19 Eric Bone Anhydrous composition in the form of a film comprising at least one film-forming polymer and at least one oxidation dye, preparation, and dyeing process
US20080120792A1 (en) * 2005-02-28 2008-05-29 Gregory Plos Dyeing of in Particular Human Keratin Materials by Dry Thermal Transfer of a Direct Azomethine Dye, Composition Comprising the Said Dye and its Method of Preparation
US7722680B2 (en) 2005-02-28 2010-05-25 L'oreal S.A. Dyeing of human keratin materials by dry thermal transfer of a direct dye, composition comprising the said dye and its method of preparation
US20060265817A1 (en) * 2005-03-31 2006-11-30 Frederic Legrand Dye composition comprising at least one non-ionic associative polymer and process for dyeing keratin fibers using same
US7651533B2 (en) 2005-03-31 2010-01-26 Oreal Dye composition with a reduced content of starting materials, process for dyeing keratin fibers using the same and device therefor
US7578854B2 (en) 2005-03-31 2009-08-25 L'oreal S.A. Dye composition comprising at least one fatty acid ester and process for dyeing keratin fibers using the same
US7442214B2 (en) 2005-03-31 2008-10-28 L'oreal S.A. Dye composition comprising at least one non-ionic associative polymer and process for dyeing keratin fibers using same
US7575605B2 (en) 2005-03-31 2009-08-18 L'oreal S.A. Dye composition comprising at least one glycerol ester and a process for dyeing keratin fibers using the composition
US7569078B2 (en) 2005-03-31 2009-08-04 L'oreal S.A. Dye composition comprising at least one cellulose and process for dyeing keratin fibers using the dye composition
US7550015B2 (en) 2005-03-31 2009-06-23 L'oreal S.A. Dye composition with a reduced content of starting materials, and process for dyeing keratin fibers using the same
US7497878B2 (en) 2005-06-30 2009-03-03 L'oreal, S.A. Azo dyes containing a sulphonamide or amide function for the dyeing of human keratin fibers and method of dyeing and dyeing compositions containing them
US20070044253A1 (en) * 2005-08-25 2007-03-01 Sylvain Kravtchenko Dye composition comprising at least one insoluble compound and processes using this composition
US20070044252A1 (en) * 2005-08-25 2007-03-01 Sylvain Kravtchenko Oxidizing composition comprising insoluble compounds, and processes using this composition
US7776104B2 (en) 2005-08-25 2010-08-17 L'oreal S.A. Oxidizing composition comprising insoluble compounds, and processes using this composition
US20070044251A1 (en) * 2005-08-25 2007-03-01 Sylvain Kravtchenko Direct dye composition comprising at least one insoluble oxygenated compound, and processes using this composition
US7651534B2 (en) 2005-08-25 2010-01-26 L'oreal Sa Direct dye composition comprising at least one insoluble oxygenated compound, and processes using this composition
US7905925B2 (en) 2005-08-25 2011-03-15 L'oreal S.A. Dye composition comprising at least one insoluble compound and processes using this composition
US20070234487A1 (en) * 2006-03-28 2007-10-11 Alain Lagrange Dye composition comprising at least one cationic hydrazone direct dye, dyeing process, and multi-compartment devices
US7481847B2 (en) 2006-03-28 2009-01-27 L'oreal S.A. Dye composition comprising at least one cationic hydrazone direct dye, dyeing process, and multi-compartment devices
US20080052840A1 (en) * 2006-05-22 2008-03-06 Maxime De Boni Use of an anionic hydrotrope for the colouring of keratinous fibres, composition comprising it and colouring processes employing it
US20080086824A1 (en) * 2006-05-22 2008-04-17 Maxime De Boni Use of a cationic hydrotrope for the direct dyeing of keratinous fibres, composition comprising it and colouring processes employing it
US7678157B2 (en) 2006-05-22 2010-03-16 L'oreal S.A. Use of an anionic hydrotrope for the colouring of keratinous fibres, composition comprising it and colouring processes employing it
US7559956B2 (en) 2006-05-22 2009-07-14 L'oreal S.A. Use of a cationic hydrotrope for the direct dyeing of keratinous fibres, composition comprising it and colouring processes employing it
US20090044348A1 (en) * 2007-06-22 2009-02-19 Aziz Fadli Coloring composition comprising at least one azomethine compound with a pyrazolinone unit
US7582123B2 (en) 2007-06-22 2009-09-01 L'oreal S.A. Coloring composition comprising at least one azomethine compound with a pyrazolinone unit

Also Published As

Publication number Publication date
CA2405024A1 (en) 2003-03-26
EP1297819A2 (en) 2003-04-02
HUP0203172A2 (en) 2003-08-28
KR100533486B1 (en) 2005-12-05
CN1410047A (en) 2003-04-16
HU0203172D0 (en) 2002-11-28
JP2003128525A (en) 2003-05-08
JP2005247867A (en) 2005-09-15
KR20030027736A (en) 2003-04-07
JP4094624B2 (en) 2008-06-04
RU2223744C1 (en) 2004-02-20
FR2829926B1 (en) 2004-10-01
BR0204142A (en) 2003-09-16
MXPA02009381A (en) 2004-08-12
EP1297819A3 (en) 2004-03-03
CN1245150C (en) 2006-03-15
US20030106169A1 (en) 2003-06-12
RU2002125634A (en) 2004-03-27
FR2829926A1 (en) 2003-03-28
PL356288A1 (en) 2003-04-07

Similar Documents

Publication Publication Date Title
US6824570B2 (en) Composition for dyeing human keratin fibres, comprising a particular monocationic monoazo dye
US7407516B2 (en) Dyeing composition for keratinous fibers comprising a dicationic diazo dye
US6893471B2 (en) Dyeing composition for keratinous fibers comprising a particular dicationic diazo dye
US7001436B2 (en) Dyeing composition for keratinous fibres comprising a particular dicationic diazo dye
KR100681746B1 (en) Particular cationic diazo compounds, compositions comprising them as direct dye, process for dyeing keratin fibres and device therefor
US7208586B2 (en) Cationic diazo compounds, compositions comprising them as direct dye, process for dyeing keratin fibers and device therefor
KR20060067914A (en) Symmetrical diazo compounds containing 2-imidazolium groups and a non-cationic linker, compositions comprising them, method of colouring, and device
US8097046B2 (en) Dye composition comprising at least one insoluble compound and processes using this composition
KR20060066607A (en) Cationic diazo compounds, compositions comprising them as direct dye, process for dyeing keratin fibres and device therefor
US9226883B2 (en) Particular azomethine direct dyes, dye composition comprising at least one such compound, implementation process therefore and use thereof
US7326258B2 (en) Compositions comprising hydroxyalkyl direct dyes, implementation processes and uses thereof
KR20060054013A (en) Dicationic bis-hydrazone compound, dye composition comprising at least one such compound, implementation process therefor and uses thereof
US20060085923A1 (en) Dye composition comprising a naphthoylene-benzimidazolium direct dye, process for dyeing keratin fibers and uses thereof
US7329289B2 (en) Use of triarylmethane derivatives as direct dyes in a dye composition, composition and implementation process
KR100947843B1 (en) Specific naphthalimide-type dyes, dye composition comprising at least one such dye, process using same and uses
US7282068B2 (en) Polycationic azo compounds for dyeing keratin fibers, dye composition containing the same, and methods for making such compounds
US7410506B2 (en) Dicationic bis-hydrazone compound, dye composition comprising at least one such compound, implementation process therefor and uses thereof
KR20070073939A (en) Particular dissymmetrical cationic polyazo compounds, compositions comprising them as direct dye, process for dyeing keratin fibres and device therefor
JP2005213246A (en) Specific bis-secondary para-phenylene diamine, dyestuff composition containing the same and method for dyeing by using the same
US7288122B2 (en) Cationic diazo compounds, compositions comprising them as direct dye, process for dyeing keratin fibers and device therefor
KR20070073937A (en) Symmetrical cationic tetraazo compounds, for dyeing keratin fibres
US20080263785A1 (en) Polycationic monochromophoric hydrazone compounds, dye compositions comprising such polycationic compounds and dyeing process using them
JP2008539212A (en) Dyeing composition comprising a dye and a propylene glycol derivative
US20050132507A1 (en) Tertiary p-phenylenediamines, dyes compositions, and dyeing processes

Legal Events

Date Code Title Description
AS Assignment

Owner name: L'OREAL S.A., FRANCE

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:VIDAL, LAURENT;FADLI, AZIZ;REEL/FRAME:013605/0225

Effective date: 20021007

FEPP Fee payment procedure

Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

CC Certificate of correction
FPAY Fee payment

Year of fee payment: 4

REMI Maintenance fee reminder mailed
LAPS Lapse for failure to pay maintenance fees
STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362

FP Lapsed due to failure to pay maintenance fee

Effective date: 20121130